The QualityStocks Daily Friday, January 13th, 2023

Today's Top 3 Investment Newsletters

QualityStocks(AAPJ) $0.0058 +65.71%

The Stock Dork(ZVSA) $3.4600 +37.30%

Tiny Gems(QBTS) $1.6800 +25.37%

The QualityStocks Daily Stock List

iPower Inc. (IPW)

Trades Of The Day, StocksEarning, QualityStocks and MarketBeat reported earlier on iPower Inc. (IPW), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

iPower Inc. (NASDAQ: IPW) is an online hydroponic equipment supplier that is engaged in the provision of hydroponics equipment online.

The firm has its headquarters in Duarte, California and was incorporated in 2018, on April 11th by Allan Huang and Chenlong Tan. Prior to its name change in September 2020, the firm was known as BZRTH Inc. It serves consumers around the globe.

The company operates and owns the retail website, where it sells over 23,000 stock keeping units as well as other products, which allow consumers to grow flowers, fruits and vegetables, as well as other plants like marijuana. It also leases about 72,000 ft2 of floor area space across a pair of fulfillment centers in California.

The enterprise’s products include pumps, trimming machines, hydroponic water-resistant grow tents, growing media, nutrients, activated carbon filters, ventilation systems, greenhouse and advanced indoor grow-light systems and accessories for hydroponic gardening, as well as other outdoor and indoor growing products under the Simple Deluxe and iPower brands. The enterprise provides roughly 3,000 private label products which are marketed under the aforementioned brands. In addition to selling its products through its website, it sells its products via 3rd party e-commerce channels like Amazon.

The firm recently launched a new line of advanced nutrient products dubbed Flourish. This move will positively affect margin expansion for the firm but also bring in more revenue into the company. This is in addition to extending its consumer reach through the use of Amazon, which is available globally.

iPower Inc. (IPW), closed Friday's trading session at $0.77, up 50.42%, on 637,226 volume. The average volume for the last 3 months is 26.493M and the stock's 52-week low/high is $0.35/$2.35.


We reported earlier on AAP Inc. (AAPJ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

AAP Inc. (OTC: AAPJ) is engaged in the provision of power, comfort and control systems for trailers, specialty vehicles, trucks, motor coaches and other applications.

The firm has its headquarters in Milford, Virginia and was incorporated in 1929 by Arthur Taubman. Prior to its name change in September 2011, the firm was known as Borneo Energy USA Inc. It operates as part of the motor vehicle and motor vehicle parts and supplies merchant wholesalers’ industry. The firm has three companies in its corporate family and serves consumers around the globe.

The company’sobjective is to create an organization which services and markets high tech products for demanding industries. It operates through the Independents and Worldpac, Carquest Canada, Southern Division and Northern Division segments.

The enterprise’s products include power transfer switches, electrical start assist devices, DC electrical systems, automatic computerized voltage disconnect systems, coolers, icemakers, freezers/refrigerators, sound attenuating foams, air purifiers, battery chargers and inverters, HVAC accessories and air conditioning/heating systems. It serves the special purpose vehicle, luxury motor coach, trucking, recreational vehicle, race car transporter, rescue, fire, medical and communication industries. The enterprise offers its products under the Vitrifrigo America, Domestic and AAP Inc. brands.

The company recently entered into a partnership agreement with North Star Developers LLC. This move enhances the company’s prospects for achieving its goals and adds to the company’s diverse and growing portfolio of businesses as well as its financial strength. The company is focused on solid business opportunities with attractive growth potential.

AAP Inc. (AAPJ), closed Friday's trading session at $0.0058, up 65.7143%, on 26,493,260 volume. The average volume for the last 3 months is 25,611 and the stock's 52-week low/high is $0.0019/$0.0477.

Wheeler Real Estate Investment Trust (WHLR)

Wall Street Resources, Market Intelligence Center Alert, Zacks, TradersPro, StreetInsider, StockMarketWatch,, MarketBeat, StockRockandRoll, RedChip, PennyStockLocks, Penny Stock 101, Money Morning and Investors Alley reported earlier on Wheeler Real Estate Investment Trust (WHLR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Wheeler Real Estate Investment Trust Inc. (NASDAQ: WHLR) is a fully integrated, self-managed commercial real estate investment firm that is focused on operating and owning income-producing retail properties with a central focus on grocery-anchored centers.

The firm has its headquarters in Virginia Beach, Virginia and was incorporated in 2011, on June 23rd. It operates as part of the REIT-retail industry, under the real estate sector. The firm serves consumers in the United States.

The company is dedicated to opportunistically acquiring and re-invigorating well-located, potentially dominant retail properties that generate attractive risk-adjusted returns. It invests in neighborhood centers, strip shopping centers, grocery-anchored centers, free-standing retail properties and community centers situated in secondary and tertiary markets. The company generates its revenues primarily from rents received from tenants under leases at the properties.

The enterprise’s portfolio comprises of 62 properties, including 58 retail shopping centers, and four undeveloped land parcels. The properties are geographically located in the Northeast, Mid-Atlantic and Southeast. They include the Franklin village shopping center in Franklin village; Bryan Station in Lexington, Kentucky; Alex City Marketplace in Alexander City, Alabama; Clover Plaza in Clover, South Carolina; Cardinal Plaza in Henderson, North Carolina; and Winslow Plaza in Sicklerville, New Jersey, among others.

The firm, which recently announced its latest financial results, remains focused on entering into strategic partnerships that directly influence the success of its portfolio. This will drive profitability for its current as well as future investors and help the firm create value for its shareholders.

Wheeler Real Estate Investment Trust (WHLR), closed Friday's trading session at $1.7301, up 1.7706%, on 25,611 volume. The average volume for the last 3 months is 200 and the stock's 52-week low/high is $1.13/$3.37.

Ensign Energy Services (ESVIF)

MarketBeat, QualityStocks, Trades Of The Day, StreetInsider and Daily Trade Alert reported earlier on Ensign Energy Services (ESVIF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Ensign Energy Services Inc. (OTC: ESVIF) (TSE: ESI) is a company engaged in the provision of oilfield services to the natural gas and crude oil industries.

The firm has its headquarters in Calgary, Canada and was incorporated in 1987, on March 31st. It operates as part of the oil and gas drilling industry, under the energy sector. The firm serves consumers around the globe, with a focus on those in the United States and Canada.

The enterprise’s offerings include specialized drilling services, including underbalanced, horizontal entry and slant drilling for steam assisted gravity drainage applications; as well as shallow, intermediate, and deep well drilling. It also offers equipment as well as coring and oil sands drilling services to the oil and natural gas and mining industries; shallow to deep well services, such as completions, abandonments, production workovers, and bottom hole pump changes for oil and natural gas producers; and interactive pressure drilling services with self-contained systems comprising nitrogen generation and compression equipment, and surface control systems. This is in addition to offering directional drilling and related services for conventional and horizontal drilling applications; and transportation services. Furthermore, the enterprise rents drill strings, tanks, loaders, blowout preventers, pumps, rig mattings, waste bins, and wastewater treatment equipment for the drilling and completions segments of the oilfield industry. As of December 2021, it operated a fleet of 262 land drilling rigs, 100 well servicing rigs and 21 specialty-coring rigs.

The company recently announced its latest financial results, which show significant increases in its revenues. It remains focused on becoming the largest and most technologically advanced oilfield service provider globally, which will bolster its overall growth considerably.

Ensign Energy Services (ESVIF), closed Friday's trading session at $2.89, even for the day, on 200 volume. The average volume for the last 3 months is 20,940 and the stock's 52-week low/high is $1.52/$3.90.

NanoXplore (NNXPF)

We reported earlier on NanoXplore (NNXPF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

NanoXplore Inc. (OTC: NNXPF) (TSE: GRA) (FRA: N13) is a graphene firm that is focused on manufacturing and supplying graphene powder for use in industrial markets.

The firm has its headquarters in Montreal, Canada and was incorporated in 1995, on May 15th by Soroush Nazarpour. It operates as part of the chemicals industry, under the basic materials sector. The firm serves consumers around the globe, with a focus on those in Canada, the United States, Switzerland and France.

The company is the largest graphene powder producer in the world with a fully automated 4,000-metric ton per year facility in Montreal, Quebec. It owns its innovative, proprietary and patent-protected graphene manufacturing technology that provides a significant cost-effective solution to customers in high-volume applications. Geographically, the company generates most of its revenue from the United States.

The enterprise offers graphene-based solutions, including GrapheneBlack powder and graphene-enhanced masterbatch pellets. It also provides standard and custom graphene-enhanced plastic and composite products to customers in electronics, transportation, packaging and other industrial sectors. This is in addition to offering graphene-enhanced sheet molding compounds used to create lightweight composite exterior and battery enclosure parts for trucks and cars, such as hoods, roofs, bumpers and battery packs.

The firm recently entered into an asset purchase agreement to acquire XG Sciences Inc.’s mechanical milling platform, research and development lab and all issued and pending patents and trademarks. This move will open it up to new growth and investment opportunities and generate shareholder value.

NanoXplore (NNXPF), closed Friday's trading session at $2.152, off by 3.4978%, on 20,940 volume. The average volume for the last 3 months is 44,536 and the stock's 52-week low/high is $1.51/$4.80.

Mitie Group (MITFF)

MarketBeat reported earlier on Mitie Group (MITFF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Mitie Group Plc (OTC: MITFF) (LON: MTO) (FRA: MZ4) is a holding firm engaged in the provision of strategic outsourcing services.

The firm has its headquarters in London, the United Kingdom and was incorporated in 1987 by David Malcolm Telling and Ian Reginald Stewart. It operates as part of the specialty business services industry, under the industrials sector. The firm primarily serves consumers in the United Kingdom.

The enterprise operates through the Business Services, Technical Services, Central Government & Defense (CG&D), Communities, Care & Custody, Landscapes, Waste, and Spain segments. It offers security services, such as manned guarding and technology-backed monitoring solutions, fire and security systems installations, vetting and front-of-house services; and general, specialist, and technical cleaning services in offices, buildings, transport and logistics hubs, and high-security environments. It also provides maintenance, repair, and mechanical and electrical project activities; technology-backed engineering; energy, carbon, and water management services; telecoms and energy services; air conditioning and disinfection solutions; and remote asset monitoring, and digital and connected workplace solutions. In addition, the enterprise offers facilities management services across central government and defense contracts; decarbonization solutions; and engineering services. Further, it provides integrated facilities management services to devolved public sector customers, which focuses on community environments in healthcare, schools and universities, emergency services, and local authorities; public services in immigration, criminal justice, and healthcare; portering services; horticultural and winter landscaping services; and waste elimination, reduction, recycling, and treatment solutions.

The company recently announced its latest financial results, with its CEO noting that they remained focused on investing in future growth through new acquisitions. This will help create value for the company’s shareholders.

Mitie Group (MITFF), closed Friday's trading session at $0.91, even for the day. The average volume for the last 3 months is 22,400 and the stock's 52-week low/high is $0.58/$0.98.

Red 5 Limited (REDLF)

We reported earlier on Red 5 Limited (REDLF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Red 5 Limited (OTC: REDLF) (ASX: RED) (FRA: RKM) is a gold exploration and mining firm that is focused on exploring for, producing and mining gold deposits and mineral properties in Australia and the Philippines.

The firm has its headquarters in West Perth, Australia and was incorporated in 1995, on March 20th. It operates as part of the gold industry, under the basic materials sector. The firm serves consumers around the globe.

The company is founded on strong health, safety and environment practices. It has a strong institutional shareholder base, with a significant number of international and domestic institutions, including cornerstone investors Franklin Resources Inc (US), Victor Smorgon Group (Australia), Electrum Group (US), Regal Funds Management (Australia) and Ruffer LLP (UK).The company operates through its subsidiaries, which include Estuary Resources Pty Ltd, Bremer Resources Pty Ltd, Oakborough Pty Ltd, Darlot Mining Company Pty Ltd and Bremer Binaliw Corporation.

The enterprise’s portfolio includes the Siana Gold project, the King of the Hills gold project and the Darlot Gold mine. The Siana gold project is located in the Island of Mindanao, the Philippines. It operates this project through its Philippine affiliated company, Greenstone Resources Corporation. The King of the Hills gold project is located in the Eastern Goldfields of Western Australia while the Darlot Gold mine is situated in the north-east of Perth in Western Australia.

The firm remains focuses on building a sustainable business, expanding and developing. This will help generate value for its shareholders and bolster its overall growth, which will in turn positively influence investments into the firm.

Red 5 Limited (REDLF), closed Friday's trading session at $0.206712, even for the day. The average volume for the last 3 months is 102,912 and the stock's 52-week low/high is $0.07/$0.3412.

Atlas Lithium Corporation (ATLX)

QualityStocks and MarketClub Analysis reported earlier on Atlas Lithium Corporation (ATLX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Atlas Lithium (NASDAQ: ATLX), a U.S. mineral exploration company with lithium projects and properties in other critical battery metals, has announced the closing of its underwritten public offering of 675,000 shares of common stock and Nasdaq uplisting. The underwriters additionally exercised the over-allotment option to purchase an additional 101,250 shares of common stock. According to the update, the shares began trading on the Nasdaq Capital Market under the ticker symbol ATLX on Jan. 10, 2023. EF Hutton Acquisition Corp. (NASDAQ: EFHTU), division of Benchmark Investments LLC, acted as sole book-running manager for the offering.

To view the full press release, visit

About Atlas Lithium Corporation

Atlas Lithium is focused on advancing and developing its 100%-owned hard-rock lithium project which consists of 52 mineral rights spread over 56,078 acres (227 km2) and is located primarily in the Lithium Valley of the state of Minas Gerais in Brazil. Atlas Lithium also has a separate second lithium project located in Brazil’s Northeast region. In total, Atlas Lithium has 100% ownership of mineral rights for almost all battery metals including lithium (293 km2), nickel (222 km2), rare earths (122 km2), titanium (89 km2), and graphite (56 km2), in addition to mining concessions for gold, diamonds and sand. The company also owns approximately 45% of Apollo Resources Corp. (private company; iron) and approximately 28% of Jupiter Gold Corp. (OTCQB: JUPGF) (gold and quartzite). For more information about Atlas Lithium, visit

Atlas Lithium Corporation (ATLX), closed Friday's trading session at $7.5362, up 1.0214%, on 102,912 volume. The average volume for the last 3 months is 5.24M and the stock's 52-week low/high is $2.925/$23.5125.

Canaan Inc. (CAN)

QualityStocks, MarketClub Analysis, Schaeffer's, InvestorPlace, TradersPro, StreetInsider, MarketBeat, Stockhouse, AllPennyStocks, INO Market Report, BUYINS.NET, InvestorsUnderground, Stock Fortune Teller, Trades Of The Day, StockMarketWatch, StocksEarning, The Online Investor, The Street, TopStockAnalysts and SmarTrend Newsletters reported earlier on Canaan Inc. (CAN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Blockchain technology has the capacity to remarkably change how multilateral payments are done. Presently, transborder payments are unhurried and costly because a series of intermediaries are involved, coupled with compounded regulatory demands. Blockchain technology can essentially regulate this process and quicken it, thereby making it cheaper, and more efficient. 

A way to change crossborder blockchain payments would be to decrease the number of middlemen involved. At present, transborder payments pass through several banks and a number of checkout processes among other mediators before arriving at their final destination. Each intermediary levies a service fee, which can hike the overall cost of payment. 

Blockchain technology could potentially annihilate a number of intermediaries by allowing direct payments to be made from one party to another, thus reducing the cost of payments and easing accessibility to individuals and enterprises. 

Blockchain could also change transborder payments by increasing transparency and lowering fraud risks. Across-the-border payments are vulnerable to financial crimes because a chain of parties and complex transactions are involved in such undertakings. Blockchain should allow tracking and verifying of each of those transactions in a secure and clear manner.  

Blockchain could potentially quicken transborder payments. As it is, transborder payments take fairly long to go through because it is mandatory that they pass through standard regulatory checks. But with blockchain, there is a possibility for transactions to be completed almost instantly, without the need for a middleman and regulative approvals. This would enable individuals to have easy access to use their monies and, consequently, cut the costs of cross-border payments.  

Ultimately, blockchain is in a position to increase financial inclusion through the provision of alternative means for persons and enterprises in third world countries to access financial services. A lot of people in these countries have no access to conventional financial services, such as banks. By using blockchain, these individuals have the potential to obtain financial services and be included in the global economy. 

In short, blockchain technology has the capacity to significantly revolutionize the way international payments are made. This could be done by reducing the number of middle persons involved, enlarging transparency and lowering fraud risk. Blockchain could hasten payments in an efficient way while also increasing financial inclusivity. Granted, potential challenges and risks are linked with blockchain, but there is a greater potential to influence and alter the flow of international payments. 

As more use cases of blockchain tech are deployed in the field, major actors in the industry such as Canaan Inc. (NASDAQ: CAN) could see explosive growth in the years to come. 

Canaan Inc. (CAN), closed Friday's trading session at $2.95, up 5.3571%, on 5,239,593 volume. The average volume for the last 3 months is 263,446 and the stock's 52-week low/high is $1.87/$6.90.

Compass Pathways PLC (CMPS)

QualityStocks, InvestorPlace, MarketBeat, Daily Trade Alert, StreetInsider, Schaeffer's, Trades Of The Day and The Street reported earlier on Compass Pathways PLC (CMPS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Officials in Colorado are seeking people to join its first psychedelics advisory board, which will inform the state on how to implement psychedelics legalization after voters approved a reform measure on last year’s ballot. The state’s Department of Regulatory Agencies has provided a web page where individuals can fill out applications to be considered. Applicants will be required to provide information on their basic background and qualifications.

The Natural Medicine Advisory Board will have 15 members, all of whom will be appointed by Governor Jared Polis.

The board members will be responsible for ensuring that research is conducted on psychedelics and making recommendations on various issues associated with psychedelics law, which allows individuals aged 21 and above to possess, grow and share certain psychedelics.

The recommendations in question will cover a range of topics, including the regulation of natural plants and fungi, promotion of public education on psychedelic reform, ensuring equitable, culturally responsible and ethical access to these natural medicines and the potential inclusion of other substances to the state’s therapeutic program.

Governor Polis is expected to make appointments to the psychedelic advisory board by Jan. 31, 2023. Once this process is finalized, board members will be required to submit their initial report with policy recommendations by Sept. 30, 2023.

Late last month, the governor certified the November vote through a proclamation, effectively legalizing the possession, cultivation and sharing of ibogaine, psilocybin, DMT, psilocin and mescaline (not derived from peyote) for individuals aged 21 and above.

The measure approved by voters in the state also legalizes personal use amounts of the aforementioned substances. Despite this, the commercial sale of these substances remains illegal at the federal level.

The new law also permits the establishment of psilocybin-healing centers in the state. Regulators will have until Jan. 1, 2024, to set up rules for trained facilitators who will work at the centers. They are also required to implement the therapeutic program and start accepting license applications by Sept. 30, 2024.

While only psilocin and psilocybin will be administered at the healing centers initially, this is expected to change as the board is required to start submitting recommendations on other psychedelics that can be administered at the centers by June 1, 2026.

In other news, Polis signed a legislation last year that would align the state’s statute to legalize MDMA prescriptions if and when the drug’s use was permitted by the federal government.

As this psychedelics program gets underway in Colorado, entities such as Compass Pathways PLC (NASDAQ: CMPS) are taking the direction of conducting clinical trials so that the treatments they develop can be approved by the FDA and commercialized through the country’s healthcare system.

Compass Pathways PLC (CMPS), closed Friday's trading session at $9.55, up 3.2432%, on 263,446 volume. The average volume for the last 3 months is 8.99M and the stock's 52-week low/high is $6.54/$21.50.

Hecla Mining Company (HL)

MarketClub Analysis, SmarTrend Newsletters, Schaeffer's, InvestorPlace, Wyatt Investment Research, MarketBeat,, StocksEarning, Top Pros' Top Picks, QualityStocks, TopStockAnalysts, StreetAuthority Daily, Market Report, The Street, Money Morning, Zacks,, Jason Bond, Kiplinger Today, Daily Trade Alert, StreetInsider, Today's Financial News, Wall Street Grand, Trades Of The Day, TheStockAdvisors, Streetwise Reports, StockOodles, The Wealth Report, TradersPro, Gryphon Digest, Penny Detectives, National Inflation Association, SureMoney, TradingAuthority Daily, Stockhouse, Darwin Investing Network, ChartAdvisor, PennyStockLive, Options Elite, INO Market Report, Wall Street Daily, Penny Sleuth, Profit Confidential, ProfitableTrading, TraderPower, The Growth Stock Wire, Daily Markets, Greenbackers, Forbes, DrStockPick, Wealth Insider Alert, TradingMarkets, WealthMakers, Investopedia, CustomerService, CRWEWallStreet, CRWEPicks, CRWEFinance, Weiss Research, BestOtc, Barchart, Daily Wealth,, AllPennyStocks, PennyToBuck, MonsterStocksPicks, Residual Income Report, Money and Markets, Rockwell Trading, Investing Futures, Stock Stars, Traders For Cash Flow, StockHotTips, Trade of the Week, InvestorGuide, Investor Update, Investor Guide, Investing Lab, PennyOmega and SmallCapVoice reported earlier on Hecla Mining Company (HL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

A new online survey conducted by Kitco shows that most retail investors expect silver and gold to be top performers this year. Silver ended 2022 up by almost 3% while gold finished flat. Spot silver kicked off 2022 at $23.28 an ounce and ended it at $23.93 an ounce, while spot gold opened last year at $1,828 per ounce and ended the year at around $1,822 per ounce.

Carsten Fritsch, an analyst at Commerzbank, stated that the price of gold was at the same level it was when 2022 began. Precious metals faced their biggest macro hurdle last year when the Federal Reserve tightened its cycle, causing a rapid hike in rates. Overall, rates rose by between 4.25% to 4.5% in 2022, by 425 basis points. Fritsch noted that considering the headwind generated by the rate hikes implemented by central banks, the performance of the silver, gold and platinum prices was exceptional.

This year, analysts expect silver and gold to do well as markets begin pricing in a Federal Reserve pivot.

The survey involved 896 respondents, with the results showing that 36.8% of retail investors expect silver to be a top performer in 2023 while 37.5% opted for gold. Copper was the third most popular asset, garnering 8% of the vote from retail investors.

The survey also shows that 4.7% of the vote was divided between Bitcoin and oil, with lithium and platinum also garnering 3.7% each. Data from the survey shows that palladium was a least favorite among retail investors, receiving less than 1% of the votes.

Analysts expect gold to rally given the current state of affairs, with the U.S. economy entering a recession, the Federal Reserve tightening monetary policy and the dollar peaking.

Dan Hynes, a senior commodity strategist at Australia and New Zealand Banking Group, also expects gold to outperform other markets as the recession progresses.

Everett Millman, a precious metals expert at Gainesville Coins, stated in an interview that silver had a lot of potential at its current price level despite being neglected by investors. Millman expects that silver will outperform gold; however, he also noted that noting that the available supply for silver investment products has been getting tighter, which may be an issue.

John LaForge, the head of real asset strategy at Wells Fargo, expects that while both gold and silver will do well in 2023, silver may perform better. Wells Fargo expects gold to reach between $1,900 and $2,000 this year, with LaForge noting that any movements in price indicate that the price may go even higher. Silver producers such as Hecla Mining Company (NYSE: HL) can possibly look forward to offering great shareholder value over the coming years.

Hecla Mining Company (HL), closed Friday's trading session at $6.23, up 4.1806%, on 8,990,174 volume. The average volume for the last 3 months is 5.497M and the stock's 52-week low/high is $3.41/$7.66.

Cenntro Electric Group Ltd. (CENN)

QualityStocks, TradersPro and InvestorPlace reported earlier on Cenntro Electric Group Ltd. (CENN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Last year, the total EV sales for the BMW Group was at 215,755, which accounted for more than double the sales made in 2021. These sales came from the company’s BMW and Mini models. In addition, the BMW Group managed to deliver the 500,000th purely electric vehicle to the owner by the close of 2022.

BMW made 103,855 BEV sales in 2021. As a result, 2022 represents a 107.7% increase. Out of the total of about 2,400,000 vehicles sold by the Group in 2022, about 9% were electric. In 2023, BMW intends to sell 15% all-electric vehicles.

The company maintained its top spot in the world’s luxury class last year, selling 2,100,692 cars overall, down by 5.1%. In electric automobiles, the BMW model also experienced significant growth. For the entire year, electric vehicle sales, including PHEVs, increased by 35.6%, totaling 372,956 units. MINI brand sales were at 292,923, a 3% decrease from vehicles sold in 2021. However, in 2022, the electric Mini brand vehicles sales, including PHEVs, were 60,839, an increase of 14.3% of vehicles, or about 21% of all MINI global sales.

BMW Group has high hopes for the year 2023 and aims to adhere to the plan, making profits throughout the year. Its main focus is to continue to increase the rate of EV adoption. The turning point of 2023 is ensuring that fully electrified vehicles account for 15% of overall vehicle sales. With BMW i5 being introduced toward the end of the year, BMW is definitely moving closer to electrifying all their vehicles.

Simultaneously, the company is advancing the digitalization of both its sales and marketing strategies. Moving forward, the BMW Group will depend on direct selling in 24 markets in Europe with the help of sales agents in order to provide a smooth transition in between the online and physical client experiences. The overall goal of this newly formed agent model is to increase customer satisfaction, elevate BMW luxury brands and connect with the tech-savvy clients.

BMW’s agency model will also be used to promote transparency in pricing and guarantee uniformity of product distribution throughout all distribution channels. This year, BMW Group will establish guidelines for the launch of the MINI brand in 2024, followed by the BMW brand in 2026. In addition, the retail associates will be closely involved in the implementation process.

One of the key components in realigning sales is the My BMW/MINI app; it leads customers into the best market experience, thanks to its various features and simple, useful links. Every day, 2 million users in roughly 50 markets use the My BMW/MINI app as a gateway to personalized client communication.

As other companies such as Cenntro Electric Group Ltd. (NASDAQ: CENN) also strive to consolidate their positions in the market segments they have selected, EV penetration is likely to progress around the world at an increasing pace.

Cenntro Electric Group Ltd. (CENN), closed Friday's trading session at $0.5338, up 0.319489%, on 5,497,458 volume. The average volume for the last 3 months is 287,678 and the stock's 52-week low/high is $0.26/$3.19.

The QualityStocks Company Corner

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV)

The QualityStocks Daily Newsletter would like to spotlight BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV).

BiondVax (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing andcommercializing innovative immunotherapeutic products primarily forthe treatment of infectious and autoimmune diseases, recentlyannounced statistically significant (p<0.001) efficacy resultsin a preclinical in-vivo proof-of-concept study of its innovativeinhaled nanosized antibody (“NanoAb”) COVID-19 therapy. “The studyconcluded that compared to pre-infection weight, the controlgroup’s weight declined on average at 12.01%. In contrast, onaverage, the weight of the experimental group using BiondVax’sNanoAb therapy declined only 3.80%. The successful result of thestudy was further supported by eight other tracked parameters,including heart rate and social behaviors, indicating that thegroup treated with NanoAbs experienced a milder, shorter illness,”a recent article reads. “BiondVax is developing a pipeline ofalpaca-derived NanoAb therapies to address diseases with largeunderserved medical needs, including COVID-19, asthma, psoriasis,psoriatic arthritis, and macular degeneration. Compared withcurrent monoclonal antibodies (‘mAbs’) treatments, BiondVax’sNanoAbs exhibit strong potential for superior patient convenience,safety and clinical outcomes, at a lower cost.”

To view the full article, visit

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) is a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses.

In collaboration with the prestigious Max Planck Institute for Multidisciplinary Sciences (MPG) and the University Medical Center Göttingen (UMG), both in Germany, BiondVax is developing a pipeline of innovative nanosized antibody (NanoAb) therapies addressing diseases underserved by current treatments and with large and growing markets, such as COVID-19, asthma and psoriasis.

NanoAbs, also known as VHH-antibodies or Nanobodies, are alpaca-derived nanosized antibodies that exhibit multiple significant competitive advantages over existing antibody therapies, including stability at high temperatures, superior binding affinity, more effective and convenient routes of administration and efficient production. BiondVax is uniquely positioned to advance nanosized antibody innovation from R&D through commercialization.

The company’s highly experienced and successful pharmaceutical industry leadership team includes former senior executives from Novartis, GSK and Bristol-Myers Squibb.

Since its founding, BiondVax has executed eight clinical trials, including a seven-country, 12,400-participant Phase 3 trial of a prior influenza vaccine candidate, and it built, owns and operates a 20,000 sq. ft. state-of-the-art GMP biologics manufacturing facility housing its laboratories, production facilities and offices.

Lead Candidate: Inhaled COVID-19 NanoAb

In December 2021, BiondVax signed definitive agreements with the Max Planck Society – parent organization of the Max Planck Institute for Multidisciplinary Sciences– and the UMG to enter a strategic collaboration for the development and commercialization of innovative COVID-19 NanoAbs.

The company is planning a rapid development path that leverages its expertise and capabilities in biological drug development and manufacturing. BiondVax anticipates preclinical proof-of-concept results for an inhaled COVID-19 NanoAb by the end of 2022, with initial Phase 1/2a human clinical trial results expected in 2023.

The intended inhaled mechanism of delivery of BiondVax’s COVID-19 NanoAb formulation may serve as a significant differentiator when compared to approved monoclonal antibodies, which are injected. Inhaled delivery has shown to be cheaper, more convenient and likely safer for patients and providers.

NanoAb Pipeline: Psoriasis, Asthma and More

The COVID-19 NanoAb development agreement is part of a broader five-year research collaboration agreement signed in March 2022 covering discovery, development and commercialization of NanoAbs for several other disease indications with large market medical needs, including asthma, psoriasis, macular degeneration and psoriatic arthritis.

BiondVax has an exclusive worldwide license for development and commercialization of COVID-19 NanoAbs and exclusive options for similar worldwide licenses for NanoAbs for the above mentioned additional large market disorders currently underserved by approved therapeutic antibodies.

Academic research teams from MPG and UMG have verified strong affinity by the new NanoAbs to their biological target molecules and high thermostability. They have also demonstrated strong neutralization by several NanoAb candidates of their respective target molecules. Neutralization studies of the other NanoAbs are expected to begin later in 2022.

Based on the promising results, BiondVax will focus development efforts beginning with the following NanoAbs:

  • NanoAbs targeting IL-17 as drug candidates for the potential treatment of psoriasis and psoriatic arthritis
  • NanoAbs targeting IL-13 and NanoAbs targeting TSLP as drug candidates for the potential treatment of asthma

These are conditions for which the antibody target is validated by existing treatments and the mechanism of action is well understood. Both represent large medical needs and growing markets. BiondVax anticipates preclinical proof-of-concept for at least one of these NanoAbs in 2023. This is in addition to the aforementioned human clinical Phase 1/2a for the inhaled COVID-19 NanoAb therapy, which is also anticipated in 2023.

Market Opportunity

COVID-19 treatment, target of the company’s lead NanoAb therapy candidate, had an estimated market size of $22 billion in 2021.

Future BiondVax drug candidates will target conditions with large markets growing at attractive CAGRs.

The global asthma treatment market was valued at $18.08 billion in 2019 and is projected to reach $26.01 billion by 2027, exhibiting a CAGR of 4.5% during the forecast period, according to Fortune Business Insights. The research firm predicts that the global psoriasis treatment market will grow from $26.37 billion in 2022 to $47.24 billion by 2029, exhibiting a CAGR of 8.7% over the forecast period.

Management Team

Amir Reichman is BiondVax’s CEO. He previously was Head of Global Vaccines Engineering Core Technologies at GSK Vaccines in Belgium. Prior to that, he held leadership roles at Novartis Vaccines’ Global Vaccines Supply Chain Management organization. He was the first employee of NeuroDerm Ltd., a company focused on transdermal drug delivery, and served as Chief Engineer and Senior Scientist until his departure in 2009. He earned a M.Sc. in Biotechnology Engineering from Ben-Gurion University and an MBA in Finance and Health Care Management from the University of Pennsylvania’s Wharton School.

Tamar Ben-Yedidia, Ph.D., is Chief Science Officer at BiondVax. She has more than 30 years of experience in immunology, with specific expertise in the development of vaccines. She began her career with Biotechnology General Ltd., working on development of a recombinant Hepatitis-B vaccine. She later joined the Weizmann Institute of Science, working on the design of a peptide-based vaccine against several pathogens. She is widely published, with numerous refereed articles and invited reviews in various scientific journals. She received her Ph.D. from the Weizmann Institute.

Elad Mark is COO at BiondVax. He has over 15 years of biotechnology industry experience encompassing diverse project stages including feasibility studies, conceptual and detailed design, commissioning, qualification and process validation. Prior to joining BiondVax, he led Novartis’s $800 million investment in a biologics facility in Singapore. With Biopharmax and Antero, both global pharmaceutical engineering companies, he successfully led projects in Israel, China and Singapore. He holds a BSc. in Engineering from the Afeka Tel Aviv Academic College of Engineering and an MBA from the Open University of Israel.

Uri Ben-Or is CFO at BiondVax. He has served as CFO with public life science companies traded on the TASE, OTC and Nasdaq. Ben-Or provides his services to BiondVax through CFO Direct, a company he founded and for which he serves as CEO. He served as the VP of Finance of Glycominds, a leading biotechnology company, and as CFO of a spin-off from Telrad Networks. He also served as a Corporate Controller at Menorah Capital Markets and as an Auditor at PWC. He holds a B.A. in Business from the College of Administration, an MBA from Bar-Ilan University, and is a CPA.

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), closed Friday's trading session at $2.82, up 7.6336%, on 287,678 volume. The average volume for the last 3 months is 4,298 and the stock's 52-week low/high is $2.37/$22.90.

Recent News

Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF)

The QualityStocks Daily Newsletter would like to spotlight Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF).

Eloro Resources’ (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) EVP of Exploration Bill Pearson was recently part of an interviewon Business TV (“BTV”) where he expressed his optimism on thecompany’s prospects following its recent exploratory work at itsIska Iska project located in southern Bolivia. “[Pearson alsosimultaneously suggested] that the possibility that Eloro couldpotentially uncover a world-class, multimillion-ounce deposit ofsilver and tin within the Iska Iska project may not be far off fromthe realm of possibility. Over the past two years, Eloro Resourceshas drilled upwards of 102 holes and over 70,000 cumulative metersacross a tract of land measuring eight square kilometers;remarkably, according to Pearson, with every single drill holeboasting multiple intersections, the company had yet to come up dryon any of its initial probes. Eloro will now look to formulate itsmaiden resource estimate, with the upcoming publication of itsinitial NI 43-101 report providing the market with furtherscientific and technical information about the economic viabilityof its project,” a recent article reads. “There’s going to be a lotof good news coming out through the fall and culminating in the MRE(mineral resource estimation),” Pearson is quoted as saying. “Thereis a lot of upside in this story as we move forward with ourinitial MRE and, ultimately, that will lead to looking at possibledevelopments down the road. There will be a major mine in Iska Iskaone day, and it probably won’t be in such a distant future.”

To view the full article, visit

Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) is a publicly traded exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec.

The company has an option to acquire a 99% interest in the highly prospective Iska Iska Property, classified as a silver-tin polymetallic epithermal-porphyry complex, a significant mineral deposit type in the Potosi Department of southern Bolivia. Iska Iska is a road-accessible, royalty-free property.

Eloro also owns an 82% interest in the La Victoria Gold/Silver Project, located in the North-Central Mineral Belt of Peru, some 50 kilometers south of Barrick’s Lagunas Norte Gold Mine and Pan American Silver’s La Arena Gold Mine. La Victoria consists of eight mining concessions and eight mining claims encompassing approximately 89 square kilometers. La Victoria has good infrastructure, with access to road, water and electricity, and is located at an altitude that ranges from 3,150 meters to 4,400 meters above sea level.

The company has a strong management and technical team working diligently to uncover the value of both Iska Iska and La Victoria. Eloro is based in Toronto, Canada.


Iska Iska – Potosi, Bolivia

Iska Iska is associated with a Miocene possibly collapsed/resurgent caldera, emplaced on Ordovician age rocks with major breccia pipes, dacitic domes and hydrothermal breccias. The property is wholly controlled by the title holder, Empresa Minera Villegas S.R.L. It is located 48 kilometers north of Tupiza city, in the Sud Chichas Province of the Department of Potosi. This is an important mineral deposit type in the prolific South Mineral Belt of Bolivia. Eloro commissioned a NI 43-101 Technical Report on Iska Iska, which was completed by Micon International Limited and is available on Eloro’s website and under its filings on SEDAR.

A fully financed drill program is currently underway on the property, situated near world-class deposits including Silver Sand, San Bartolomé, Pulacayo, San Cristobal, San Vicente, Chorolque, Tasna, Choroma and Siete Suyos. Iska Iska is in the southwest part of the Eastern Cordillera, which hosts a number of major polymetallic mines and mineral deposits. Drilling and continuous channel sampling results have demonstrated some very high metal values, especially silver and tin, within an immense system, where mineralization has been encountered in every drill hole to date. The company believes there is excellent potential for world-class bulk mineable deposits.

La Victoria – Ancash, Peru

The La Victoria project, targeting gold and silver production, is situated near world-class, low-cost gold producers Pan American Silver and Barrick Gold Corporation. Located in Ancash Department, La Victoria sits on the western slopes of the Peruvian Andes. The property is located 12 hours from Lima, with a travel distance of 600 kilometers. The nearest road accessible population centers from La Victoria are Huandoval, Pallasca and Cabana. The project includes four principal mineralized zones in Peru’s prolific North-Central Mineral Belt – San Markito, Victoria, Victoria South and Ccori Orcco – with excellent potential for gold discovery. Operations at La Victoria are planned to proceed with a 2,000-meter diamond drilling program to test targets to outline potential resources at San Markito. Trenching and sampling confirmed high silver values and veins at San Markito in 2020.

Market Outlook

According to industry association The Silver Institute, the outlook for silver demand is exceptionally promising, with global demand forecast to rise to a record high of 1.112 billion ounces in 2022. The increase will be driven by record silver industrial fabrication, which is forecast to improve by 5%, as silver’s use expands primarily in solar energy and electric vehicle (EV) manufacturing. The institute states that government commitments to carbon neutrality have resulted in a rapid expansion of green energy projects, driving record photovoltaic panel installations which are expected to lift silver demand in this segment to an all-time high in 2022.

Rising demand in the electronics industry is also boosting the demand for tin, which is primarily used in solder. The electronics and electrical industries use solders containing 40-70% tin, which provide strong and reliable joints under a variety of environmental conditions. At present, the majority of the assemblers are using patented tin-and-copper-based solders. Mordor Intelligence estimated tin demand at 387 kilotons in 2021 and forecasts demand growth of 2.5% annually through 2027. Over the medium term, surging demand from the EV market and increasing applications in the electrical and electronics industry is expected to drive the market.

Management Team

Thomas G. Larsen is CEO of Eloro. He has more than 40 years of experience in the investment industry, specializing in corporate finance and management of junior resource companies, raising in excess of C$200 million. He previously held the position of President and Chief Executive Officer of Champion Iron Limited. Prior to that, he was President and Chief Executive Officer of Champion Iron Mines Limited.

Dr. Bill Pearson is Executive VP of Exploration for Eloro. He has more than 40 years of direct experience in the exploration and production of minerals worldwide. He played an integral role in the acquisitions of Desert Sun Mining Corp. by Yamana Gold in 2006 and Central Sun Mining by B2 Gold in 2009. He was formerly VP Exploration at Desert Sun Mining and Senior VP at Central Sun Mining.

Miles Nagamatsu, CPA, is CFO at Eloro. He has over 30 years of experience in accounting, management, lending, restructurings and turnarounds. Since 1993, he has acted as a CFO of public and private companies primarily in the mineral exploration and investment management sectors. He holds a Bachelor of Commerce degree from McMaster University.

Osvaldo Arce Burgoa is General Manager at Eloro. He is a geological and mineral processing engineer with 26 years of experience in Bolivia. He is a former President of the Bolivian Geological Society, Main Technical Advisor of the National Mining Corporation (COMIBOL) and has served as exploration manager and chief geologist at various mining and exploration companies. He has authored two books on Bolivian geology and holds a doctorate in mining engineering from Tohoku University in Sendai, Japan.

Eloro Resources Ltd. (OTCQX: ELRRF), closed Friday's trading session at $2.605, up 2.0928%, on 4,298 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $22.90/$.

Recent News

Jupiter Wellness Inc. (NASDAQ: JUPW)

The QualityStocks Daily Newsletter would like to spotlight Jupiter Wellness Inc. (NASDAQ: JUPW).

Jupiter Wellness (NASDAQ: JUPW), a company focused on hair, skin and sexual wellness, is in anideal position to be “profitable” in 2023. That was the outlookreported in a shareholder letter released by JUPW CEO Brian John.The letter noted 2022 highlights, such as the company becoming thesecond U.S. equity to dual list on Upstream, a revolutionarytrading app for digital securities and NFTs, and JUPW’s SRMEntertainment division submitting a confidential registrationstatement to the SEC on a key step on its journey to becoming anindependently traded NASDAQ company. The letter also noted thatJupiter Wellness had expanded to the Indian market with itsPhotofirst product and had seen its NoStingz sunscreen registerrecord sales during the January Surf Expo in Orlando. In addition,the company reported record revenues in 2022 with plans for evenmore success in 2023, based on a license agreement with TaishoPharmaceutical Co. Ltd. to sell Minoxidil Booster and Photocil inthe Japanese market and Sanpellegrino Cosmetics Pvt Ltd &Cosmofix Technovation Pvt Ltd. in the Indian market and 31 othercountries. The letter added that Jupiter will be developingrevolutionary prescription products through an exclusive licensingagreement with Rejoy Inc. “As we look forward to 2023, the entireexecutive team at Jupiter Wellness is grateful for your support andcommitment to our success,” wrote Jupiter Wellness CEO Brian Johnin the shareholder letter. “With your help, we have been able tolay the groundwork for even greater financial growth, monetizationof our clinical trial programs, improvements in profitability, andan increase in shareholder value.”

To view the full press release, visit

Jupiter Wellness Inc. (NASDAQ: JUPW) is a diversified company that supports health and wellness by researching and developing over-the-counter (OTC) products and intellectual property. The company has a robust and growing portfolio of granted and pending patents to protect its proprietary products.

Jupiter Wellness’s product pipeline, backed by clinical research to ensure efficacy, addresses a range of underserved conditions. The company’s revenue is generated through a combination of OTC and consumer product sales, contract research agreements, and licensing royalties.

Jupiter Wellness was formed in 2018 and is headquartered in Jupiter, Florida.

Products with Purpose

Jupiter Wellness’s product pipeline currently targets a variety of indications with underserved needs. These include:

  • Hair Loss – Jupiter Wellness’s Minoxidil Booster is a topical treatment that’s been clinically shown to increase the enzymes needed for minoxidil to work by up to 7x over a two-week period. The product has been licensed to Taisho, a $2.6 billion revenue company and Japan’s leading seller of minoxidil products, which expects to launch it commercially in 2023. The product is licensed to India-based Cosmofix Technovation Pvt. Ltd. and Sanpellegrino Cosmetics, and additional licensing opportunities are being pursued.
  • Psoriasis & VitiligoPhotocil safely and effectively permits phototherapy treatments at home by blocking harmful radiation and permitting the passage of therapeutic UV radiation. The product has been licensed abroad and is currently being launched commercially in India by Eris Oaknet Healthcare and Cosmofix Technovation under the brand name PhotoFirst. The product is also available in the U.S., and the company is working to find new partners in dermatology for expanded distribution.
  • Jellyfish Protection SunscreenNoStingz is a topical protection from jellyfish, sea lice, and UVA/UVB rays. It provides an effective barrier against the stinging mechanism of jellyfish cnidocytes, preventing the delivery of venom to the victim. NoStingz is currently available online through Amazon and Walmart, as well as in select stores.
  • EczemaJW-100 is a pre-revenue topical treatment for atopic dermatitis (eczema). In prior studies, JW-100 cleared or reduced eczema symptoms following 2 weeks of use. Results suggest that JW-100 may potentially prove superior to existing prescription drugs. It is currently being evaluated in a Phase 3, double-blind, placebo-controlled multicenter trial.
  • BurnsJW-300 is a pre-revenue topical treatment for first-degree burns and sun exposure. In prior studies, JW-300 was shown to significantly lower the incidence of burns in patients exposed to UV radiation. It is currently being evaluated for sale as an “after sun” consumer product.
  • Cold SoresJW-400 is a pre-revenue topical treatment of herpes labialis (cold sores). A phase 1, double-blind, placebo-controlled investigational study is currently being planned for JW-400.
  • Sexual WellnessJW-500 is a pre-revenue topical treatment for female libido loss. In clinical studies, the topical formulation improved nipple sensitivity and alleviated associated sexual problems. Jupiter Wellness plans to file for a pre-IND meeting with the U.S. FDA within the next 12 months and intends to seek Orphan Drug Designation.
  • COVID-19-Induced TinnitusJW-600 is currently being evaluated in a triple-blind clinical study. Up to 15% of patients recovering from COVID-19 have experienced post-acute COVID-19-induced tinnitus

Management Team

Brian John is the CEO of Jupiter Wellness. For the past 20 years, he has been an investor and advisor to companies around the globe. He is the founder of a successful financial consulting firm specializing in helping emerging growth companies and has worked with hundreds of companies in dozens of countries over the last 25 years. Mr. John also serves on the board of directors of The Learning Center at the Els Center of Excellence – a school for children with autism in Jupiter, Florida.

Doug McKinnon is the CFO of Jupiter Wellness. His 35+ year professional career includes financial, advisory, and operational experience across a broad spectrum of industry sectors, including oil and gas, technology, cannabis, and communications. He has served in C-Level positions in both private and public sectors, including as chairman and CEO of an American-stock-exchange-traded company; as VP – Chief Administrative Officer of a $12-billion-market-cap Nasdaq-traded company; as CFO of several publicly-held U.S., Canadian and Australian companies; and as CEO/CFO of various other private enterprises.

Dr. Glynn Wilson is the Chief Scientific Officer of Jupiter Wellness. He brings to the company an extensive background of success in corporate management and product development with tenures in both multinational and start-up biotech organizations. He was formerly Head of Drug Delivery at SmithKline Beecham Pharmaceuticals; Research Area Head in Advanced Drug Delivery at Ciba-Geigy Pharmaceuticals; and Founder, CEO, and Chairman of TapImmune Inc., which became Marker Therapeutics through a merger. At TapImmune, he licensed cancer vaccine technology platforms and established the clinical pipeline.

Jupiter Wellness Inc. (NASDAQ: JUPW), closed Monday's trading session at $2.05, up 3.0151%, on 73,251 volume with 375 trades. The average volume for the last 3 months is 57,207 and the stock's 52-week low/high is $1.04999995/$5.63000011.

Recent News

Tingo Inc. (OTCQB: TMNA)

The QualityStocks Daily Newsletter would like to spotlight Tingo Inc. (TMNA).

Tingo (OTC: TMNA), a leading agrifintech business in Africa, and Dozy Mmobuosi,renowned technology entrepreneur and philanthropist, have togetherunveiled the Dozy Mmobuosi Leadership Centre (DMLC), located inOxford, United Kingdom. The centre is designed to offer amonthlong, in-person transformational leadership program forentrepreneurs and those involved in both private and publicservice. The centre is scheduled to welcome its first cohort ofapproximately 35 African leaders in February 2023. The centre canalso be used as a meeting point for world leaders and researchersfor high-level events. According to the announcement, Rt. Hon. MarkSimmonds will serve as the chair of the centre. Simmonds haspreviously served as the Parliamentary Under Secretary of State atthe Foreign and Commonwealth Office. “The Dozy Mmobuosi LeadershipCentre is a transformational and innovative mission to provideAfrican entrepreneurs and sectoral leaders with access to highlevel motivation and mentoring of next generation leaders,” saidthe Dozy Mmobuosi Leadership Centre chair Mark Simmonds in thepress release. “The centre will provide the foundation to driveimpact and nurture future leaders in global society. . . . Theprogram based near Oxford will enable these outstanding Africans todevelop and enhance skills in leadership, governance, motivation,finance, technology and innovation. Providing access to some of theworld’s most inspirational leaders, ensuring enhanced human capitalof young Africans to help their businesses grow and to accelerateAfrica’s economic and social development.’’ To view the full pressrelease, visit A recent report released by Steven Goulden, a senior analyst atCumberland, has identified a number of “green shoots” that could emerge in the cryptocurrency market in 2023 in spite of this year’s turbulent cryptocurrency collapses andprice drops. Goulden highlights four new trends in the report, titled “Year in Review,” that in the next two years willsignificantly advance the cryptocurrency market. These trendsinclude Web3 apps and games becoming genuinely popular, NFTs beingthe go-to approach for tokenizing a brand’s IP, and Bitcoin andEther possibly being adopted as a nation’s reserve asset. Whileacknowledging that it has been extremely difficult to overthrowWeb2 monopolies, Goulden believes that the use of Web3 applicationsthat offer “practical utility” will begin to pick up steam in 2023.This is exemplified by entities that are focusing on bringingblockchain technology into different aspects of the agriculturalsector, such as Tingo Inc. (OTC: TMNA).

Tingo Inc. (OTCQB: TMNA) is a digital service agri-fintech technology company focused on foundation-level agriculture and related financial services in Africa. The company aims to be Africa’s leading agri-fintech player, transforming rural farming communities to connect through its proprietary platform to meet their complete needs – from inputs and agronomy to off take and marketplace – and deliver sustainable income in an impactful way. The company’s vision is to build complete digitally inclusive ecosystems that promote financial inclusion and deliver disruptive micro-finance solutions, empower societies, produce social upliftment in rural communities and open international opportunities.

Tingo believes that a truly connected world will help contribute to a better global society. The company’s core focus areas are telecoms, financial services/fintech and agritech. Tingo’s goal is to provide a best-in-class customer experience, support the domestic economies of its host countries and support technological and financial inclusion to end the poverty premium. Through this, Tingo hopes to deliver attractive returns to shareholders while investing in the long-term future of the company and its subsidiaries.

Global climate change is challenging sustainable production and food security. Tingo’s strategy and market execution provide an opportunity for Africa to be a core focal point to solve a number of key areas of concern, including food security, gender equality, financial inclusion and poverty alleviation, to name a few. Disruption of micro finance through the use of DeFi-based stable coins and smart contracts will give agri-communities access to capital markets-driven digital finance solutions that make them more competitive and sustainable economically, striking a good balance of returns between digital asset providers and Tingo as the service partner. This innovation will deliver significant access to much needed finance at ‘Grassroot’ levels, delivering tangible social upliftment and GDP growth in the African markets served by Tingo.

Tingo Mobile, with more than nine million subscribers, is Nigeria’s leading technology and device-as-a-service platform aimed at accelerating digital commerce, especially in the country’s agritech and fintech verticals. The company helps farmers acquire mobile phones through a unique leasing plan, connecting them to mobile and data networks through its own virtual mobile network. Tingo also connects farmers to markets, services and resources via Nwassa, its digital agritech marketplace platform that commenced operations in 2020. The company has also launched a beta version of TingoPay – a B2B and B2C fintech app aimed at providing financial services to users inside and outside of the agriculture value chain. Among the services offered are mobile wallets, payment processing and access to specialist lenders, insurers and pension products.

Tingo will soon announce its innovative blockchain-based solution for use of digital stable coins to empower frictionless trade across borders in Africa. The company’s market-proven model in Nigeria is its core foundation, enabling Tingo to deliver the same service model across Africa to become the continent’s leading agri-fintech business powered through smartphone technology.

The African Continental Free Trade (ACFT) plan will be a key framework to prepare the company to be the leading intra-Africa trading hub for trade flows across Africa in the medium term, when it is likely the agreement will be executed into tangible activity. Tingo is well positioned to easily transform the goals of the ACFT into reality when finally implemented by the African Union and the various African countries that have not signed up.

Tingo posted total revenue of $594 million in 2020, with $212 million EBITDA. As of December 31, 2020, Tingo has 9,344,000 subscribers. The company is confident that these figures will grow through its expansion across Africa and natural progression of business in Nigeria.


Tingo has four core businesses:

  • Mobile Phone Leasing – Tingo has distributed almost 30 million mobile handsets since 2014 and will continue to replace the devices of its installed customer base every three years. Tingo Mobile provides the latest mobile phone handsets at an affordable price point and allows customers to spread payments over 36 months.
  • Mobile Voice and Data Service – Through a mobile virtual network, Tingo provides its customers with voice and data services, allowing customers to communicate effectively, both inside and outside the agricultural ecosystem.
  • Nwassa Marketplace Platform – Nwassa is Tingo’s proprietary agritech platform which provides Africa’s farmers with access to global markets to secure more competitive pricing for their crops. The platform processes 500,000 daily transactions with a value of over $8 million. A select group of trusted partners can assist smallholder farmers and agricultural cooperatives with packaging, warehousing, and dry and wet cargo logistics, as well as up-to-date information from the global agricultural sector. Tingo provides its customers with digital wallet services, which enable them to send and receive domestic payments, monitor cash flow in real time and securely hold money. The company also provides access to other services, such as utility bill payment, virtual airtime top-up, insurance services and alternative lending solutions.
  • TingoPay – Since the launch of the Nwassa platform, Tingo has been a dominant player in the B2B fintech vertical. After many successful months of operating Nwassa, Tingo entered the fintech B2C vertical to extend its B2B offering to a broader market beyond agriculture.

TingoPay is still in its beta phase and will launch in 2021 with a comprehensive marketing campaign. TingoPay offers the following services:

  • Tingo Wallet top-up
  • Peer to Peer payments, inclusive of merchant payments at the stores
  • Utility payments – airtime, broadband, cable, electricity, water, hotel, flights etc.
  • Pension payments
  • QR code payment services

Market Opportunity

Africa is the second-largest continent by population. It is also the youngest by far, with a median age of 18 for its 1.3 billion people. Tingo believes the building blocks for growth in Africa’s agriculture industry are in place and that the company is well positioned to participate in the upside. Sub-Saharan Africa’s population is growing at a rate of 2.7 percent per year. At the current growth rate, the continent’s population will double by 2050. Africa’s youthfulness represents a significant opportunity for material growth in demand for agricultural commodities. This younger generation is also being born into a digital world and is comfortable using technology.

Africa’s governments are improving business conditions for entrepreneurs and small businesses. Sub-Saharan Africa’s World Bank Doing Business rank has improved from 45 in 2004 to 65 in 2020. Tingo believes this trend will continue and encourage establishment of more new ventures across all economic sectors, including agriculture.

Africa attracted $407 billion of Foreign Direct Investments (“FDI”) between 2014 and 2018. Investments are increasingly focused on services and industrial sectors. Only 20 percent of investments are in extractive industries – a clear reversal from 2008, when 55 percent of FDI was aimed at resource extraction. Tingo believes FDI into Africa will help resolve significant infrastructure constraints and create value for agribusiness.

Management Team

Dozy Mmobuosi is the CEO of Tingo. He cofounded Tingo Mobile PLC (Nigeria) in 2001 and led the design and launch of Nigeria’s first SMS banking solution, which is still in use in the country today. He also headed a team of more than 120 Chinese and Nigerian engineers in the construction of two mobile phone assembly plants in Nigeria, which have produced and distributed 20 million phones across the country. He has led Tingo’s growth to more than $600 million in revenue annually. He holds a Ph.D. in Rural Advancement from UPM Malaysia.

Dakshesh Patel is the CFO of Tingo. He was formerly CFO of NatWest’s Global Debt and Investment Banking division. He has served as a Director at Gerken Capital Associates, a San Francisco-based alternative asset fund manager. He also led the restructure of Lloyds Banking Group (last financial crisis); managed integration of two leading shipping groups’ global treasury function to create world-leading shipping group Maersk Shipping; built three fintech companies; and exited one to Worldpay. Mr. Patel has strong banking experience, with a focus on Africa. He is a chartered accountant.

Chris Cleverly is president of Tingo. He has served as CEO of the Made in Africa Foundation, and as CEO of blockchain payments gateway startup Kamari. He has been a board member of several companies, both public and private, in the UK, India, China and Africa. He has advised multiple UK companies on their entrance into African markets, and regularly advises the UK Government on development issues and African governments on investment issues.

Clarence Simms is the Chief Technology Officer at Tingo. He has 25 years of IT and IT management experience. He has worked in IT Shared Services Technical Operations and IT Program Management for Huawei Technologies and MTN. As an entrepreneur, he created, a service that allows African Diaspora travelers to send airtime, pay bills, send mobile money and transfer money to a bank account from anyplace in the world.

Rory Bowen is the Chief of Staff at Tingo. Mr. Bowen started his career in traditional capital and derivatives markets working for Moneycorp and Tradition UK in European and emerging markets across FX, interest rate derivative and government bond markets. He has also spent time with one of Europe’s fastest growing fintech’s banking circles. Before joining Tingo, he was Chief of Staff at FinTech Alliance, an organization established in partnership with the UK Government Department for International Trade to foster innovation, growth and foreign direct investment (FDI) in the financial services sector and facilitate greater public/private cooperation.

Tingo Inc. (OTCQB: TMNA), closed Friday's trading session at $0.45, up 2.2727%, on 10,800 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.01/$6.00.

Recent News

MetAlert Inc. (OTC: MLRT)

The QualityStocks Daily Newsletter would like to spotlight MetAlert Inc. (OTC: MLRT).

MetAlert recently released its yearend shareholder update letter,covering the past year’s progress, and associated plans for 2023,all focused on helping to monitor the safety and location ofdementia patients and other vulnerable individuals

Coupled with concerns about patients with Alzheimer’s disease orother brain conditions that may lead toward risks of themwandering, becoming lost or disoriented, or falling, the situationdemonstrates an opportunity for remote monitoring of patients’whereabouts

To meet the need, MetAlert developed a pioneering wearableGPS-enabled tracking device a decade ago that unobtrusively slipsinto wearers’ shoes

The company has since expanded the device’s capabilities in keepingwith developments in remote patient monitoring technology andinsurance company recognition to monitor falls, wandering, andother health concerns

Following a year of wearable technology advances together with arebranding and restructuring drive, medical patient location devicedeveloper MetAlert (OTC: MLRT) is working with shareholders to demonstrate the “significantpotential” for market value found in MetAlert’s GPS two-waytracking technologies.

MetAlert Inc. (OTC: MLRT) is a pioneer in location sensitive health monitoring devices (estimated $47 billion industry in 2021) and wearable technology products (industry forecast to reach $174 billion by 2030).

With over 20 years of experience and an extensive patent portfolio (30+), MetAlert is a leader for consumers/patients afflicted with Alzheimer’s, dementia, and autism (ADA). This market represents approximately 2.9% of the world’s population (approximately 34 million people in 24 developed countries). Due to specific behaviors (problems with memory, adversity to wearing unknown items, etc.) of consumers/patients in this market segment, traditional products, such as an iPhone or Fitbit, are not a practical solution. This has created a significant market with very few competitors for MetAlert.

MetAlert and its subsidiaries are engaged in designing, developing, manufacturing, distributing, and selling products and services in GPS/BLE wearable technology, personal location, wandering assistive technology, and health data collection and monitoring. The company offers a global end-to-end hardware, software, and connectivity solution, in addition to developing two-way tracking technologies, which seamlessly integrate with consumer products and enterprise applications.

Using its award-winning, patented GPS SmartSole® as a hub for collecting and transmitting data to the cloud in real-time, MetAlert is expanding its value proposition to consumers and increasing its revenue per user (RPU) while creating the largest database of health statistics for ADA consumers/patients. MetAlert generates revenue from product sales, recurring subscriptions, intellectual property (IP) licensing, and professional services. The company has international distributors servicing customers in over 35 countries and is an approved U.S. military government contractor. Its customers include public health authorities and municipalities, emergency and law enforcement, private schools, assisted living facilities, NGOs, small business enterprises, senior care homes and consumers.

The company is headquartered in Los Angeles, California, with a sales office in London, England, and distributors across the globe.


  • GPS SmartSoles® HUB (launched Q4 2022) is a GPS/BLE-equipped insole that allows remote monitoring, data collection, and encrypted data transmission to the cloud.
    • Telehealth (available Q4 2022) allows access remotely to doctors and other health professionals on an as-needed basis. This service will also function as the prescribing doctor once Medicare reimbursement codes are established.
    • Concierge (available Q4 2022) provides 24/7/365 enhanced emergency response that coordinates with all relevant parties to quickly detect false alarms and escalate response as needed.
    • Bluetooth Enabled Devices (available Q1 2023) include third-party devices that collect vitals and other health data and connect with the GPS Smartsoles® HUB.
    • Artificial Intelligence (available Q1 2023) software will evaluate the Teradata of health information identifying trends and respond to preestablished alert thresholds.
  • Take-Along Tracker is a small GPS tracking device – less than three inches long – that works with 4G cellular service and will have the same “HUB” functionality as the GPS Smartsoles®. This versatile and affordable mini tracker boasts super long battery life, with up to 14 days of operation per charge.
  • RoomMate™ is a wall-mounted alert system that detects and alerts caregivers about patient behavior that could lead to falls and injuries. The system features 3D infrared and wall-mounted sensors, eliminating the need for any other physical installation or wearables. RoomMate™ offers patient privacy by design. Images are not stored, but all actions are logged. It’s a unique solution for looking after patients without intruding on their personal space.

Market Outlook

According to Grand View Research (Patient Monitoring Devices Market Size & Share Report, 2030), the global patient monitoring devices market size was valued at $47.0 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 7.8% from 2022 to 2030. The expansion of the industry can be attributed to the rise in demand for monitoring devices used to measure, distribute, record, and display a variety of biometric data, including blood pressure, temperature, and blood oxygen saturation level.

The growing number of chronic disorders, such as diabetes, stroke, and kidney disease, are driving the demand for patient monitoring devices. For instance, according to the World Health Organization (WHO), about 422 million people globally have diabetes. Likewise, the number of asthma and chronic obstructive pulmonary disease patients (COPD) is increasing rapidly.

According to the WHO, around 235 million people suffer from asthma. As a result, peak flow meters, which are used to gauge respiration rate, are increasingly used. The market for patient monitoring devices is driven by the simplicity with which it is handled, transported, and remotely accessible. Major market players are engaging in a variety of tactics to expand the industry, including partnerships, cooperation, innovation, launches, and mergers.

During the COVID-19 outbreak, social segregation and quarantining procedures were put into place worldwide. Many people avoided regular hospital visits as a result. Many people now need routine home temperature and oxygen level monitoring to maintain track of their health, thereby demanding monitoring devices at home.

Various government programs are supporting the pandemic outbreak. The FDA has granted Emergency Use Authorizations (EUAs) for a few wearables and patient monitoring devices to improve access to medicines, monitor patients more closely, and lessen the risk of SARS-CoV-2 exposure to medical professionals during the COVID-19 pandemic.

The growing popularity of wearable and remote patient monitoring devices is another factor fueling the market’s expansion. By fusing clinical symptomology with vital indicators, wearable technology helps in the diagnosis of many chronic diseases. Thus, there has been a dramatic rise in the usage of wearable technology to combat COVID-19.

The wearable medical device market is anticipated to reach $174.48 Billion by 2030, expanding at a 27.1% CAGR during the forecast period (2022-2030), according to Market Research Future.

MetAlert identifies the total addressable market for its wearable patient monitoring tech for those with Alzheimer’s, dementia, and autism at more than 34 million potential patients in North America, Europe, South Africa, and Asia.

Management Team

Patrick E. Bertagna is Founder, CEO and Chairman at MetAlert. He began his career in apparel sales in 1983 and was promoted to national sales manager within two years. In 1986, he founded his first company importing apparel from Europe and selling to U.S. retailers from JCPenney to Neiman Marcus. He has founded several technology and apparel companies, including MetAlert in 2002, which he took public in 2008. He attended Cal State University Northridge with a business major and a psychology minor.

Louis Rosenbaum is COO of MetAlert. He co-founded Global Trek Xploration and was an initial investor in MetAlert. He has successfully started companies in multiple industries, including apparel, environmental services, and the music industry, achieving annual revenues in the multi-millions of dollars. He previously was president of Elements, a women’s apparel company, and of Advanced Environmental Services.

Alex McKean is CFO at MetAlert. He is also the CFO of Encore Brands Inc., a position he has held since 2009. He has held positions as Controller and VP of Finance at 24:7 Film and, Director of FP&A/SVP at Franchise Mortgage Acceptance Company, Corporate Accounting Manager/Treasurer of Polygram Filmed Entertainment and Assistant Treasurer/Controller for State Street Bank. He holds an International MBA from Thunderbird School of Global Management and undergraduate degrees in business and political science from Trinity University.

MetAlert Inc. (OTC: MLRT), closed Friday's trading session at $0.395901, up 13.1792%, on 126,674 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.06/$1.00.

Recent News

REZYFi, Inc.

The QualityStocks Daily Newsletter would like to spotlight REZYFi, Inc.

  • Google will change its requirements for product ads on January20, 2023, to allow the promotion of FDA-approvedpharmaceuticals containing CBD and topical hemp-derived CBDproducts in California, Colorado, and Puerto Rico
  • Non-FDA-approved CBD topicals will require certification fromLegitScript, which will test THC compliance and review thethird-party Certificate of Analysis of each product to bepromoted
  • With the growing acceptance of cannabis, REZYFi is positionedin the financial industry as one of the first cannabis mortgagebankers in the United States

REZYFi, a specialized financing company and a growing mortgage lender, isworking to help businesses navigate the challenging landscape ofloan origination, particularly as it applies to the traditionallyunderserved cannabis industry and property owners who lease to suchcompanies. “REZYFi is anticipating the launch of its high-margincannabis division in the coming weeks to focus on such challenginglending markets. The company is developing a proprietary technologythat will help it operate competitively by maintaining efficientturnaround time while also being economical with staffing levels,”a recent article reads. “Through its subsidiaries, REZYFi Lendingand ResMac Inc., the company has closed over 20,000 loans for over15,000 clients and expects to originate $285 million retail salesduring the coming year, with $250 million in wholesale originationin motion. Now operating in 30 states, the company expects toexpand to all 50 states in the process of fulfilling its growthgoals.” To view the full article, visit

REZYFi, Inc. is a cannabis mortgage bank servicing the needs of both traditional and non-traditional consumers and businesses. Its target markets include licensed and permitted cannabis companies, owners of real estate who lease to cannabis companies, and companies and individual homeowners seeking a variety of real estate-related first and additional mortgage-based financing and project-specific financings, such as solar installations and real estate development projects.

Headquartered in Miami, Florida, REZYFi operates through two wholly owned subsidiaries – REZYFi Lending, which primarily addresses emerging real estate-related financing opportunities, and ResMac Inc., the company’s traditional mortgage origination, correspondent and servicing operation. REZYFi is currently licensed in 34 U.S. states, with plans to expand to all remaining states later this year.

REZYFi is positioned as one of first cannabis mortgage bankers in the U.S., while most traditional lenders are still reticent to serve the state-licensed cannabis industry.


REZYFi Lending

REZYFi Lending leverages a wide network to offer options such as 15- and 30-year fixed-rate loans, FHA loans, VA loans, reverse mortgages, jumbo loans and adjustable-rate mortgages.

Looking ahead, the company expects increased funding in marketing and loan agents to drive significant origination growth over the next two years, further supported by the planned launch of a high-margin cannabis division later this year.

ResMac Inc.

ResMac has been in operation for 13 years, having closed more than 20,000 loans for more than 15,000 clients. The company expects to accumulate $285 million in retail origination in 2023, alongside $250 million in wholesale origination for the same period. ResMac is further targeting $600 million in origination through its mortgage correspondent operations for 2023.

Through its ResMac subsidiary, REZYFi operates as a direct lender and originator of residential mortgages, with active mortgage correspondent and mortgage servicing operations. Through its correspondent segment, ResMac primarily purchases and aggregates residential mortgages from trusted third-party originators.

The company intends to harvest the database of customers within its mortgage servicing operations as an essential source of additional growth, especially relative to the new alternative residential loan programs being offered.

Corporate Strengths

  • Experience – REZYFi is led by a seasoned management team with significant expertise spanning a wide range of real estate and financing subsectors. The team also has extensive experience in the cannabis and hemp marketplace, which the company intends to leverage as it navigates the changing landscape of the cannabis industry while sourcing the best opportunities in the sector.
  • Network of Independent Brokers – Over the past five years, REZYFi has developed an extensive network of independent mortgage-related brokers and licensed loan officers. The company is currently training the network members on its new service offerings, with many already launching sales efforts. REZYFi believes this network will be a vital asset moving forward as other firms in the sector terminate relationships in the face of slowing mortgage business in a rising interest rate environment.
  • Proprietary Technology – REZYFi has invested heavily in designing, building and implementing proprietary automated/machine learning technology to shorten loan processing timeframes and increase efficiencies, allowing it to operate its legacy business at staffing levels meaningfully below those of its competitors.

Market Overview

REZYFi’s diversified approach to the real estate lending sector positions it to capitalize on growth in multiple verticals in the years to come.

In the first quarter of 2022, lenders issued 2.71 million residential loans, with the average balance for a first mortgage climbing to a record high of $298,324 in 2021, according to the Mortgage Bankers Association. This trend is expected to continue, with Freddie Mac forecasting a 10.4 percent increase in home prices in 2022 and a 5.0 percent bump in 2023. Growth prospects in the cannabis industry paint a similar picture.

The National Association of Realtors® issued a report in April 2021 examining the correlation between cannabis legalization and real estate demand. In states where prescription and recreational cannabis use is legal, more than a third of surveyed agents reported an increase in demand for warehouses. Likewise, 23 percent of those surveyed reported an increase in demand for storefronts, and 28 percent observed increased demand for land. As other states look to join the 19 that have embraced full cannabis legalization, this rising demand could create an opportunity for REZYFi’s cannabis-focused initiatives.

In total, an analysis by market research firm Business Research Insights projects the global loan servicing market to reach a value of nearly $1.5 billion by 2028, up from $680.8 million in 2021. Those figures represent a CAGR of 11.0 percent during the forecast period of 2022-2028.

Management Team

John Vu, Esq., is CEO of REZYFi, Inc. He has more than two decades of experience in the mortgage and commercial banking industry. He has filled many senior and executive management positions in high-producing mortgage banks, including C-level assignments. He has also served as general counsel for a nationally associated commercial bank. Mr. Vu brings considerable cannabis industry expertise to REZYFi. He has served as a corporate attorney to multiple cannabis cultivators, manufacturers and retailers.

Ji Ji Zhang, Esq., is CFO of REZYFi, Inc. He is a multifaceted entrepreneur who owns a law firm, a portfolio of hotels and a high-producing mortgage bank. Mr. Zhang is also an investor in the development of a cannabis business park. He brings more than five years of experience in mortgage banking to REZYFi, having developed Freddie Mac and HUD licenses and amassed a managed portfolio valued at over $300 million.

Kevin Heckemeyer is President of REZYFi, Inc. He has more than 25 years of experience in mortgage banking. He has built and sold several high producing mortgage businesses. In his current roles with ResMac, he is responsible for production and operations.

Spencer Dang is Chief Credit Officer of REZYFi, Inc. He has more than a decade of experience in mortgage operations. He is a direct endorsement underwriter for HUD and has specialized in non-QM underwriting. Under his watch as an underwriter, he has never had a single repurchase.

Recent News


GeoSolar Technologies Inc.

The QualityStocks Daily Newsletter would like to spotlight GeoSolar Technologies Inc.

GeoSolar Technologies (“GST”) offers its SmartGreen(TM) solution, which can be retrofitted toexisting homes or built into new developments in any climate withan installation process that takes just a few weeks. “Thecomprehensive program includes sealing and insulating the ‘shell’or ‘envelope’ of the house (exterior walls, attic, etc.),eliminating any usage of fossil fuels (natural gas, heating oil,propane) in favor of high-efficiency electric appliances andmechanicals, and installation of rooftop solar panels as the newenergy source, geothermal ground loops used in heating and cooling,electric heat pump and water heater, floor loops, LED lighting, airpurification system, and electric vehicle charging station,” arecent article reads. “‘GST plans to reinvent the home energymarket and deliver more value by creating energy efficient homes,advanced highly monitored air management, air sealing, rapidelectric vehicle personal charging stations and AI controlled homeautomation,’ the company said in announcing a Regulation A+offering… The company estimates that if every U.S. house wereoutfitted with its SmartGreen(TM) package, the country wouldeliminate 1.9 trillion pounds of carbon emissions annually.Extrapolate that to buildings and businesses, and GeoSolar Techmanagement says 60 trillion tons of emissions could be eliminatedeach year.”

To view the full article, visit

GeoSolar Technologies Inc. (“GST”) is a Colorado-based climate technology company and the creator of the Smart Green Home® system for newly built and existing residences and commercial buildings. The company is focused on revolutionizing the way we heat, cool and power homes with 100% natural energy sources. Its patent-pending integrated system harnesses energy from the earth and sun to power and purify homes and automobiles without the use of fossil fuels.

In a GST home, the sun’s energy is captured on the roof to generate all of the electricity required. Additionally, the consistent climate of the earth is used to keep the home at a perfect temperature year-round, and the company’s proprietary air purifying unit ensures that the air inside the home is safe and healthy.

GST’s home technology has been installed in multiple test homes in Colorado and achieved exceptional results, including some of the most impressive energy efficiency ratings (HERS) in the industry.

GeoSolar Technologies is currently accepting investment as part of a Regulation A+ offering. Everyone* can invest now for as little as $300. For more information, visit the company’s profile on Manhattan Street Capital and review its Offering Circular.

GeoSolar Technologies Inc. (“GST”) has been qualified by the U.S. Securities and Exchange Commission (SEC) to conduct a Regulation A+ capital raise. GST is already a publicly traded company who makes quarterly and annual filings with the SEC and is subject to quarterly PCAOB audits. This is the first time shares of GeoSolar Technologies are being made available for public purchase. Upon completion of this Regulation A+ offering, the company intends to seek a listing of its stock.


The Decarbonization Movement

Soaring and unstable energy/fuel costs continue to highlight the importance of rethinking the traditional approach to powering homes, from top to bottom. While most everyone is well aware of the remarkable, multi-trillion-dollar opportunity the electric vehicle transformation offers to investors (in addition to the benefits to the climate problem), few recognize that the all-electric home market is as large as electric vehicles and equally important to reducing carbon emissions.

U.S. energy expenditures clocked in at $3,891 per person in 2018, leading to estimated spending of $1.3 trillion on energy that year alone. Despite this, fewer than 3% of U.S. homes are currently powered by solar. This number is poised to increase exponentially as both new and existing residences transition to zero carbon models.

GST estimates that if all the homes in America were powered by its technology, carbon pollution could be reduced by an estimated 1.9 trillion pounds per year, greatly reducing the negative impacts on our climate.


The GeoSolarPlus (“GSP”) system combines solar power, geothermal ground-sourced energy and other clean energy technologies into one fully integrated system.
Key benefits of the GSP system include:

  • Making a real planet-changing difference in reducing air pollution
  • Eliminating or significantly reducing homeowners’ future utility bills
  • Enjoying lifetime energy independence and protection from price escalation and energy shortages
  • Eliminating greenhouse gas emissions from operation of home and daily life
  • Increasing home value
  • An integrated design for seamless operation of renewable energy systems
  • Maintaining a significantly healthier living environment
  • Leveraging existing renewable energy tax credits and electrification incentives
  • Creating stable jobs capable of supporting families in the decarbonized future

Click here to learn more about how GeoSolarPlus works.

Management Team

The GST leadership and management team includes some of the world’s most experienced and respected leaders in the fields of decarbonization and sustainable homes.

Stone Douglass is the Chairman and CEO of GST. He is a seasoned, 30-year public company executive and former Chairman and CEO of the Piper Aircraft Company.

Brent Mosbarger is the company’s Co-Founder and leads its commercial operations. He is a highly respected solar engineer whose experience includes roles with Chevron Energy’s green operations and serving as project manager and executive for a $400 million solar/geothermal innovation project.

Peter Romenesko is a Senior Strategic Advisor with GST. He brings to the company considerable experience as an engineer and large-scale project manager for Johnson Controls and Siemens.

Dr. Norbert Klebl is the company’s Co-Founder and Development Director. Recognized as one of the world’s leading experts in the field of zero-carbon innovation, he is a former McKinsey partner of 16 years with an MBA from Columbia.

Dar-Lon Chang is GST’s Director of New Product Development. Prior to joining GST, he had a 16-year career with ExxonMobil Energy Research. He received his PhD in engineering from the University of Illinois.

* Must be over 18, certain states are not currently available and will be added soon.

Recent News


SideChannel Inc. (OTCQB: SDCH)

The QualityStocks Daily Newsletter would like to spotlight SideChannel Inc. (OTCQB: SDCH).

SideChannel (OTCQB: SDCH) is guided by the belief that small and mid-sized businesses(“SMBs”) deserve the expertise of an experienced chief informationsecurity officer (“CISO”) just as much as a larger enterprise butat a more reasonable cost. “The company is helping organizationsall over the world improve their cybersecurity and move theirmission forward. SideChannel matches companies with an expertvirtual CISO (‘vCISO’), so companies can assess cyber risk andensure cybersecurity compliance – all without jeopardizingfinancial assets,” a recent article explains. “SideChannel sees itsrole as to make it as easy as possible for small and mid-sizedcompanies to build highly effective cybersecurity and privacyprograms… With threats becoming more complex and technology rapidlychanging, best practices must evolve. Until now, it has beenimpossible for organizations to keep up with the changing landscapewhile staying on budget. By merging proven experience with aninnovative virtual model, SideChannel acts as a natural extensionof an organization’s team – taking the time to identify theorganization’s unique security gaps and offering the services andguidance required when they are needed.”

To view the full article, visit

SideChannel Inc. (OTCQB: SDCH) simplifies cybersecurity for mid-market companies by matching them with highly experienced information security officers at a cost lower than building an in-house information security team or hiring a full-time CISO.

SideChannel’s team of virtual Chief Information Security Officers (vCISOs) possesses a combined 400-plus years of experience in cybersecurity. They’ve honed their skills and abilities in places like Anthem, Dick’s Sporting Goods, Best Buy, TD Bank and the Pentagon. SideChannel lends this talent to clients, creating value in the form of a bespoke cybersecurity program perfectly sized for the growing enterprise.

SideChannel is committed to creating top-tier cybersecurity programs for SMBs to help them protect their data and assets. To date, SideChannel has created more than 50 multi-layered cybersecurity programs for its clients.


Reports show that cyberattacks on SMBs have increased in recent years, as organizations’ network attack surfaces have grown exponentially with remote and in-office workers increasingly relying on cloud environments, mobile devices, software applications and third-party suppliers to conduct business.

SideChannel continues expanding its service offerings, workforce and customer base, attracting over 20 virtual CISOs to serve across industries including fintech, biotech, healthcare, manufacturing, legal, defense and technology services. The company is based in Worcester, Massachusetts.

Market Opportunity

An analysis from ReportLinker states that the global cybersecurity market is expected to grow from an estimated value of $173.5 billion in 2022 to $266.2 billion by 2027, recording a CAGR of 8.9% for the period.

The increased number of data breaches worldwide, the ability of malicious actors to operate from anywhere in the world, the links between cyberspace and physical systems, and the difficulty of reducing vulnerabilities and consequences in complex cyber networks are some factors driving cyber security market growth, according to the report.

A lack of cybersecurity professionals and the budget constraints among SMBs and start-ups in developing economies are expected to hinder market growth. Cybercriminals are using automated techniques to attack SMBs’ networks to take advantage of their weak security infrastructures. To save money, time and resources, SMBs are seeking cybersecurity solutions.


Enclave expands upon SideChannel’s cybersecurity service offerings by solving a pervasive network security problem with a simple tool.

A comprehensive cloud and network security solution, Enclave enables IT teams to contain breaches faster, reduce network outages, minimize latency and strengthen overall security defense.

Enclave creates the foundation for a Zero Trust network security model IT can build upon.

With Enclave, IT can easily segment their company’s network, organize personnel and computing devices at the employee workload level, and implement security controls across all network segments.

Enclave was designed and purpose built to serve the growing security needs of SMBs, a traditionally underserved market that is more prone to cyberattacks but has limited protection due to smaller budgets, inadequate IT security staffing and a lack of cybersecurity awareness among top executives.

Enclave is an affordable and effective network security solution that shrinks the attack surface area exposed to a cyber intruder and significantly reduces the amount of effort required to operate securely.

Management Team

Brian Haugli is CEO of SideChannel. He has led programs for the U.S. Department of Defense, the Pentagon, and Fortune 500 companies. He is an expert on National Institute of Standards and Technology guidance, threat intelligence implementations and strategic organizational initiatives. He is a professor at Boston College, Woods College of Advancing Studies Master’s Program in Cybersecurity. He is also a contributing author for the Wiley book ‘Cybersecurity Risk Management’.

Ryan Polk is CFO at SideChannel. He has been the principal of Perissos Partners, an executive consulting firm, since June 2017. He also served in executive roles in the portfolio companies owned by Lacy Diversified, with combined revenue approaching $2 billion. He served as the Vice President for Corporate Financial Planning and Analysis for Brightpoint, a publicly traded, Fortune 500 mobile device logistics company. He earned a bachelor’s degree in accounting and industrial management from Purdue University.

Nicholas Hnatiw is Chief Technology Officer at SideChannel. Prior to joining the company, he served as the technical director for network operations supporting U.S. Cyber Command, U.S. Intelligence Agencies and other Department of Defense research organizations. He was also the CEO of Loki Labs, a cyber security firm. He earned a bachelor’s degree in computer engineering and computer science at the University of Massachusetts, Amherst.

Bill Roberts is SideChannel’s CISO. He most recently served as the vice president, IS & CISO for Hologic Inc., a global medical device company, where he established cyber security and IT compliance programs. Prior to Hologic, he was vice president of information security for Cytyc Corporation, which was acquired by Hologic in 2007. At Cytyc, he managed global IT as the company grew from 140 employees to 1,500 and from $40 million in revenue to over $750 million.

SideChannel Inc. (OTCQB: SDCH), closed Friday's trading session at $0.09925, even for the day. The average volume for the last 3 months is and the stock's 52-week low/high is $0.06/$0.18.

Recent News

Sharing Services Global Corporation (SHRG)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

Direct-sales environment is evolving as younger generations exploreopportunity

Changing consumer behaviors, a tough regulatory environment andlingering supply chain struggles are industry challenges

SHRG’s primary growth strategy is built on focused innovation andcreativity positioned to capture profitable market share

The beginning of a new year is an ideal time to reflect on what thedirect-sales industry may look like this year, and companies suchas Sharing Services Global (OTCQB: SHRG) are likely to benefit as the space appears set to see significantgrowth.

Sharing Services Global Corporation (SHRG), formerly Sharing Services Inc., is a diversified company dedicated to maximizing shareholder value, operating through two primary subsidiaries: Elepreneurs Holdings, a direct-selling company, and Elevacity Holdings, a products company. Headquartered in Plano, Texas, SHRG markets and distributes Elevate-branded health and wellness products through an independent sales force of distributors called Elepreneurs.

Proprietary Products

SHRG’s current exclusive Elevate product offerings are marketed under the Elevacity brand, so named to signify the company’s commitment to elevating lives.

The Elevate health and wellness product line consists of nutraceutical products that SHRG refers to as D.O.S.E., which stands for dopamine, oxytocin, serotonin and endorphins – all of which are key hormones proven to promote happiness and well-being.

Elevacity brand products are carefully formulated, chosen and designed to support a single objective: elevate the happiness and well-being of the consumer.

Global Network of Elepreneurs

Elevacity products are shared and sold by a growing international network of home-based entrepreneurs, called Elepreneurs, operated by Elepreneurs Holdings. This SHRG subsidiary provides basic and advanced programs for both new and experienced entrepreneurs who are focusing on their direct-sales careers.

SHRG’s high-performing independent sales force follows the company’s Blue Ocean selling strategy, an approach that encourages individuals to seek new markets, lead, and to “stop competing and start creating.” The Blue Ocean strategy is based on the book, “Blue Ocean Strategy,” written by Professor Renée Mauborgne, who notes that “the lesson here is that the best defense is offense, and the best offense… is to make a blue ocean shift and create your own blue ocean.”

Following this selling strategy, SHRG’s Elepreneurs are taught that, rather than competing directly in a competitive, direct-selling market, they should focus on making competitors irrelevant and succeeding in an uncontested marketplace.

In addition, SHRG’s Elepreneurs use the interactive, video-based VERB sales-marketing platform developed by Verb Technology Company Inc. The app utilizes proprietary interactive video data collection and analysis technology and provides next-generation customer relationship management, lead generation, and video marketing software applications.

Continued Momentum as Industry Leader

These selling strategies have resulted in sharp and consistent revenue gains. In the company’s 10-Q filed with the SEC for the three months ended Oct. 31, 2019, SHRG reported sales of $38.8 million for fiscal Q2 2019, an increase of 116% over sales of $17.9 million reported for the comparable quarter of 2018. Consolidated gross profit jumped by $16.2 million to $27.4 million for the same period compared to Q2 2018.

SHRG’s consolidated operating earnings were $3.9 million in the fiscal quarter ended Oct. 31, 2019, compared to $866,802 for the comparable period the prior year. Consolidated gross margin also grew 70.9% for the three months ended Oct. 31, 2019, compared to 62.2% the prior year.

These numbers are continuing a trend established over the past two years. In fiscal Q1 2019, SHRG achieved revenues of $35.4 million, more than double that of the comparable period in 2018. Even earlier, the company reported sales of $85.9 million for fiscal year ended April 30, 2019. This represents a nine-fold increase, or $77.5 million jump, over the company’s revenues of $8.4 million the prior year.

These numbers bring SHRG’s sales revenues since December 2017 — when the company’s Elevate product line was released — to an impressive cumulative total of $169 million.

Preparing for Success

SHRG is well prepared to continue and accommodate for this growth. The company recently expanded its corporate footprint by moving to a 10,000-square-foot facility in Plano, Texas, that offers ample room to expand as the company grows and flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

In addition, the company has a seasoned, expert leadership team in place, led by John “JT” Thatch. Thatch was appointed president and CEO of SHRG in March 2018, bringing to the company his expertise obtained from successfully starting, owning and operating several businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist SHRG as the company aims to expand and increase revenues.

469.304.9400 x 201

Sharing Services Global Corporation (SHRG), closed the day's trading session at $1.01, up 23.17%, on 276,351 volume with 217 trades. The average volume for the last 3 months is 279,074 and the stock's 52-week low/high is $0.27/$2.54.

Recent News

CNS Pharmaceuticals Inc. (NASDAQ: CNSP)

The QualityStocks Daily Newsletter would like to spotlight CNS Pharmaceuticals Inc. (NASDAQ: CNSP).

Researchers at Brigham and Women’s Hospital may have found anotherway to treat cancer; the new approach involves transforming cancer cells into anti-cancer agents. The researchers developed the new therapy approach, which cantrain the immune system to prevent the disease from recurring whilealso eliminating primary tumors. Dr. Khalid Shah, the study’scorresponding author, stated that the group’s objective was to turncancer cells into cancer vaccines and killers. He explained thatthe scientists repurposed cancer cells using gene engineering todesign a therapy that eliminated tumor cells and stimulated theimmune system to prevent cancer and destroy established tumors.Shah is the Department of Neurosurgery’s vice chair of research at Brigham as well as the director of theCenter for Stem Cell and Translational Immunotherapy. For theirstudy, the researchers used living tumor cells, as observationshave found that the cells usually go back to the tumor cell site.This differs from prior cancer-vaccine studies, which usually useinactivated tumor cells. Brain cancers are receiving plenty ofresearch resources from the likes of CNS Pharmaceuticals Inc. (NASDAQ: CNSP) and many universities. It wouldn’t be far-fetched to forecast thatmajor breakthroughs could be on the horizon for patients afflictedwith central nervous system malignancies.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system.

The company was founded in 2017 and is headquartered in Houston, Texas.

Organ Targeted Therapeutics

The company’s lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. Berubicin also has potential to treat other central nervous system malignancies. Based on limited clinical data, Berubicin appears to be the first anthracycline to cross the blood brain barrier in the adult brain, and it was the subject of a successful Phase 1 study which found the MDT and produced efficacy data as well.

CNS holds a worldwide exclusive license to the Berubicin chemical compound. The company has acquired all requisite data and know-how from Reata Pharmaceuticals Inc. related to a completed Phase I clinical trial of Berubicin in malignant brain tumors. In this trial, 44% of patients experienced a statistically significant improvement in clinical benefit. In 2017, CNS entered into a collaboration and asset purchase agreement with Reata.

CNS intends to explore the potential of Berubicin to treat other diseases, including pancreatic and ovarian cancers and lymphoma. The company is also examining plans to develop combination therapies that include Berubicin.

CNS estimates that more than $25 million in private capital and grants were invested in Berubicin prior to the company’s $9.8 million IPO in November 2019.

CNS intends to submit an IND for Berubicin during the fourth quarter of 2020 and expects to commence a Phase II clinical trial of Berubicin for the treatment of GBM in the U.S. in Q1 2021. A sub-licensee partner was awarded a $6 million EU/Polish National Center for Research and Development grant to undertake a Phase II trial of Berubicin in adults and a first-ever Phase I trial in pediatric GBM patients in Poland in 2021.

The company’s second drug candidate, WP1244, is a novel DNA binding agent licensed from the MD Anderson Cancer Center. In preclinical studies, WP1244 proved to be 500-times more potent than the chemotherapeutic agent, daunorubicin, in inhibiting tumor cell proliferation. The company has entered into a sponsored research agreement with the MD Anderson Cancer Center to further the development of WP1244.

CNS Pharmaceuticals recently engaged U.S.-based Pharmaceutics International Inc. and Italian BSP Pharmaceuticals SpA for the production of the Berubicin drug product. The company has implemented a dual-track manufacturing strategy to mitigate COVID-19-related risks, diversify its supply chain and provide for localized availability of Berubicin. CNS has already completed synthesis of Berubicin’s active pharmaceutical ingredient (API) and has shipped the API to both manufacturers in order to prepare an injectable form of Berubicin for clinical use.

Global Brain Tumor Therapeutics Market

The high recurrence rate of malignant brain tumors is due to reappearance of focal masses, indicating that a sub-population of tumor cells in these cancers may be insensitive to current therapies and may be responsible for reinitiating tumor growth. This necessitates the development of newer drugs in the market that demonstrate greater efficacy in treating such aggressive cancers.

A global increase in neurological disorders has placed increased attention on cancers of the brain over the past decade. Neurological disorders are becoming one of the most prevalent types of disorders, due to longer life expectancy, greater exposure to infection and an increasingly sedentary lifestyle. Because few treatments for primary and metastatic cancers of the brain exist, costs are high and have acted as a restraint for the brain tumor therapeutics market.

Despite progress in surgery, radiotherapy and chemotherapeutic strategies, effective treatments for brain cancer are limited by a lack of specific therapies for the brain and the difficulty in transporting therapeutic compounds across the blood brain barrier. Therefore, there is a significant need for novel and effective therapeutic drugs and strategies that prolong survival and improve quality of life for brain tumor patients.

Several companies are making significant investments into R&D, which is expected to bring more treatment options to the market in the near future. Industry reports consistently project continued growth in the market.

One report estimates that the global brain tumor therapeutics market will reach a valuation of $2.74 billion in 2023, with the market expected to register a CAGR of 11% during the forecast period from 2018 to 2023. Another report projects that the global brain tumor therapeutics market will reach $3.4 billion by 2025, up from $2.25 billion in 2019 (

Management Team

John M. Climaco is the CEO of CNS Pharmaceuticals. For 15 years, Climaco has served in leadership roles for a variety of health care companies. Recently, Climaco served as the Executive Vice President of Perma-Fix Medical S.A, where he managed the development of a novel method to produce Technitium-99. Climaco also served as President and CEO of Axial Biotech Inc., a DNA diagnostics company. In the process of taking Axial from inception to product development to commercialization, Climaco forged strategic partnerships with Medtronic, Johnson & Johnson and Smith & Nephew.

Christopher Downs, CPA, is the company’s Chief Financial Officer. Downs previously served as Interim Chief Financial Officer and Executive Vice President of InfuSystem Holdings Inc. (NYSE: INFU), a supplier of infusion services to oncologists in the United States. Downs holds a Bachelor of Science from the United States Military Academy at West Point, an MBA from Columbia Business School and a Master of Science in Accounting from the University of Houston-Clear Lake.

Dr. Donald Picker is the Chief Scientific Officer of CNS. Picker has over 35 years of drug development experience. Prior to joining CNS, Picker worked at Johnson Matthey, where he was responsible for the development of Carboplatin, one of the world’s leading cancer drugs, which was acquired by Bristol-Myers Squibb with annual sales of over $500 million. In addition, he oversaw the development of Satraplatin and Picoplatin, third-generation platinum drugs currently in late-stage clinical development.

Sandra L. Silberman, M.D., Ph.D., is the Chief Medical Officer of CNS Pharmaceuticals. Silberman is a hematologist/oncologist who earned her B.A., Sc.M. and Ph.D. from the Johns Hopkins University School of Arts and Sciences, School of Public Health and School of Medicine, respectively, and her M.D. from Cornell University Medical College. She then completed both a clinical fellowship in hematology/oncology and a research fellowship in tumor immunology at the Brigham & Women’s Hospital and the Dana Farber Cancer Institute in Boston, Massachusetts. Silberman has played key roles in the development of many drugs, including Gleevec(TM), for which she led the global clinical development at Novartis. Silberman advanced several original, proprietary compounds into Phases I through III during her work with leading biopharmaceutical companies, including Bristol-Myers Squibb, AstraZeneca, Imclone and Roche.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP), closed Friday's trading session at $2.4, off by 3.6145%, on 23,185 volume. The average volume for the last 3 months is 23,185 and the stock's 52-week low/high is $2.05/$23.892.

Recent News

India Globalization Capital Inc. (NYSE American: IGC)

The QualityStocks Daily Newsletter would like to spotlight India Globalization Capital Inc. (NYSE American: IGC).

Cannabis has proven highly lucrative for most states with legal marijuana programs. Thanks to immense demand from the public, cannabis retailers in states such as California and Colorado havebeen selling billions of dollars’ worth of cannabis products tocustomers. State governments win big in such scenarios because theyoften receive hundreds of millions or even billions of dollars in cannabis taxes. Massachusetts is one of the latest states torake in billions in cannabis sales. Data from a recent report released by the state’s Cannabis Control Commission shows that thestate collected a whopping $1.42 billion in adult use sales betweenJan. 1 and Dec. 18, 2022. A closer look at the report reveals thatrecreational use sales of cannabis in Massachusetts increased steadily month by month. February had the lowest sales in the year at around$110.1 million while the highest sales occurred in July ($132.4million) and August ($130.8 million). Such stats for medicalcannabis sales show that the public is hungry for medicinalproducts made from marijuana and that there is a potential marketfor companies looking to develop therapeutic formulations fromcannabinoids such as THC, including India Globalization Capital Inc. (NYSE American: IGC),

India Globalization Capital Inc. (NYSE American: IGC), through subsidiary IGC Pharma, develops, patents, and markets advanced THC-based drug formulations for the treatment of symptoms related to various diseases including but not limited to Alzheimer’s disease, Tourette syndrome, chronic pain, and pet seizures.

IGC’s leading drug candidate, IGC-AD1, has completed Phase 1 of a safety and tolerability trial and entered Phase 2 trials for treating agitation in patients with Alzheimer’s dementia, the first study in humans of a natural tetrahydrocannabinol (THC) compound plus another molecule ( As of September 2022, the IGC trial is the only ongoing Phase 2 trial of a natural THC-based formulation on Alzheimer’s patients.

The company’s other drug candidate, TGR-63, is an enzyme inhibitor that has shown in preclinical trials the potential to reduce neurotoxicity in Alzheimer’s cell lines. Both drug candidates have shown their ability to ameliorate beta amyloid plaques in Alzheimer’s cell lines and improve memory in Alzheimer’s mouse models. Beta amyloid plaques are a key hallmark of Alzheimer’s and an important target of Alzheimer’s pharmaceutical drug development.

Neuro Psychiatric Symptoms (NPS) are not only debilitating for Alzheimer’s patients; they also place an immense emotional burden on their caregivers. Beyond reducing symptoms, IGC-AD1’s active molecules and TGR-63 have also shown promise in preclinical trials to reduce important hallmarks of Alzheimer’s including plaques and tangles, as well as improving the treatment of memory loss.

Over the past eight years, the IGC team has amassed a deep knowledge of cannabinoid science, including extraction, isolation, purification, and development. The company’s strategy is to leverage its unique end-to-end capabilities, platform, and expertise to develop a class-leading program and bring it to market quickly and cost efficiently to treat neurodegenerative diseases such as Alzheimer’s.

The company also has a family of cannabidiol (CBD)-based consumer products ( such as pain relief creams, pain relief gels, purpose gummies, tinctures, and capsules targeting women’s wellness, with a particular focus on premenstrual syndrome (PMS) and dysmenorrhea (period cramps). In addition, the company targets individuals that need sleep-aids with its specially formulated low melatonin cannabinoid gummies.

IGC has also introduced a low-calorie CBD- and caffeine-infused energy beverage brand ( that is currently available for purchase. The company’s brands are founded on the belief that effective natural solutions should be affordable and accessible to everyone. As the demand for natural products targeting women’s wellness and energy drinks continue to grow, these products are seeing strong traction in the market.

The company operates three facilities – a large GMP (Good Manufacturing Production Standards) certified facility that includes extraction, distillation, and manufacturing, in Washington State; a GMP-211 (pharmaceutical) grade facility in Maryland; and a facility licensed for controlled substances including cannabis in Bogota, Colombia, with complete access to legal licensed cannabis where the company conducts its testing.

In addition, the company’s development under Magistral Formulations is approved by INVIMA (Colombia National Food and Drug Surveillance Institute) to treat neurological disorders, non-oncological chronic pain, and mental disorders.

IGC’s intellectual property (IP) portfolio comprises of eight patents that it controls and seven patent applications. The portfolio includes #11,446,276, a patent for extreme low dose THC treatment of Alzheimer’s that was granted in September 2022.

The company is headquartered in Potomac, Maryland.


IGC-AD1 is the company’s leading drug candidate for the treatment and relief of Alzheimer’s symptoms. A significant amount of research on Alzheimer’s cell lines has shown that the active agents in IGC-AD1 reduce plaques and neurofibrillary tangles that are the hallmarks of Alzheimer’s. Further, micro-dosing of THC, as shown in cell lines, could increase the functioning of mitochondria and potentially promote the growth of new neural pathways (neurogenesis). The research shows that micro-dosing of THC affects the brain radically differently from the normal higher dosing of THC.

While there is a significant body of research showing that THC is neuro-toxic at normal levels of dosing, micro-dosing of THC has been shown to be non-toxic to neurons. With the results of these preclinical studies, the company developed an oral formulation, IGC-AD1. The company recently completed a safety and tolerability Phase 1 trial on Alzheimer’s patients and has initiated a Phase 2, multi-site, double-blind, randomized, placebo-controlled trial of the safety and efficacy of IGC-AD1 on agitation in participants with dementia due to Alzheimer’s disease at sites in the U.S. and Canada. IGC expects the Phase 2 trial to take between 9 and 12 months to complete, barring unknown factors such as, for example, a resurgence of COVID and the enforcement of lockdowns and travel restrictions.

With further successful trials and FDA approvals, IGC hopes to bring a drug based on natural THC as an effective treatment for agitation in Alzheimer’s to market.


The company’s other molecule, TGR-63, has been shown to reduce the neurotoxicity that impacts memory loss in preclinical trials with mice. On a dose dependent manner, transgenic Alzheimer’s mice treated with TGR-63 showed improvement in memory relative to control.

Both drug candidates, IGC-AD1 and TGR-63, have shown their ability to reduce the brain plaques associated with memory loss in Alzheimer’s in mice.

With further successful trials and FDA approvals, IGC hopes to bring TGR-63 as a treatment for Alzheimer’s disease to market.

Market Opportunity

Alzheimer’s disease impacts over 55 million people worldwide and about 5.5 million individuals in the U.S. Over 70% of these patients face debilitating symptoms, including anxiety, depression, and agitation (Mendez, 2021). Agitation in dementia patients can include excessive physical movement and verbal activity, restlessness, pacing, belligerence, aggression, screaming, crying, and wandering.

In 2020, the estimated healthcare costs for Alzheimer’s disease in the U.S. were $305 billion. Medicare and Medicaid covered about 70% of those costs, leaving considerable burden on patients and families. At the current rate of growth of Alzheimer’s and other dementia diagnoses, those costs are estimated to reach over $1 trillion by 2050.

Currently, there are no FDA-approved medications to alleviate the symptoms of dementia due to Alzheimer’s disease, providing a tremendous opportunity for formulations that can have an impact on quality of life and disease progression.

Management Team

Richard Prins has been chairman at IGC since 2012 and served as an independent director since 2007. From March 1996 to 2008, he was the Director of Investment Banking at Ferris, Baker Watts, Incorporated. Prins served in a consulting role to RBC until January 2009. He currently volunteers full time with a non-profit organization, Advancing Native Missions, and is a private investor. Since February 2003, he has been on the board of Amphastar Pharmaceuticals Inc. He holds a bachelor’s degree from Colgate University and an MBA from Oral Roberts University.

Ram Mukunda is CEO and President of IGC. He has been the chief inventor and architect of most of the company’s patent filings and is responsible for the company’s strategic positioning. Prior to IGC, he was founder and CEO of Startec Global Communications, which he took public in 1997. He served as Strategic Planning Advisor at Intelsat, a communications satellite services provider. From 2001 to 2003, he was a Council Member at Harvard’s Kennedy School of Government, Belfer Center of Science and International Affairs. He was named the 1998 Ernst & Young Entrepreneur of the Year. He holds bachelor’s degrees in electrical engineering and mathematics, and a master’s degree in engineering from the University of Maryland.

Dr. Jagadeesh Rao is the company’s Principal Scientist. His career spans two decades in the public sector and product R&D for Johnson & Johnson. He leads IGC’s scientists in the development of pharmaceutical and OTC products. He worked for the federal National Institutes of Health, and for the National Institute on Drug Abuse. His Ph.D. in Neurochemistry is from the National Institute of Mental Health & Neurosciences in India. He did postdoctoral training at the University of Illinois-Chicago.

Claudia Grimaldi is a Director, Vice President, Principal Financial Officer, and Chief Compliance Officer for IGC. She also serves as a Director/Manager Director for some of the company’s subsidiaries. She graduated with highest honors from Javeriana University in Colombia with a bachelor’s degree in psychology. She holds an MBA, graduating with highest honors, from Meredith College in North Carolina. In addition, she has attended the Darden School of Business Financial Management Executives program and the Corporate Governance Program at Columbia Business School. She is currently pursuing her Directorship Certification with the National Association of Corporate Directors. She is fluent in both English and Spanish.

India Globalization Capital Inc. (NYSE American: IGC), closed Friday's trading session at $0.3829, off by 1.5681%, on 126,664 volume. The average volume for the last 3 months is 126,664 and the stock's 52-week low/high is $0.2785/$1.16.

Recent News

Advanced Container Technologies Inc. (OTC: ACTX)

The QualityStocks Daily Newsletter would like to spotlight Advanced Container Technologies Inc. (OTC: ACTX).

Legislators in the U.S. Virgin Islands recently passed a bill to legalize cannabis for recreational use. This move brings the total number of U.S. territories and statesthat have legalized the recreational use of marijuana to 21. Thepossession of an ounce of marijuana was decriminalized in theCaribbean Island territory almost a decade ago in 2014, with thelegislature approving a bill to allow the medical use of cannabisyears later, in 2019. At the moment, the medical use of marijuana has been legalized in 37 states. However, the drug still remainsillegal at the federal level because it’s still classified as aSchedule I substance under the Controlled Substances Act. As the rulesaround cannabis cultivation become known, equipment makers such as Advanced Container Technologies Inc. (OTC: ACTX) could find themselves having an uptick in orders from licensedcannabis growers.

Advanced Container Technologies Inc. (OTC: ACTX) is in the business of selling and distributing self-contained, automated, indoor “micro-farms” called Grow Pods, along with related equipment and supplies. Additionally, the company designs and sells patented proprietary medical-grade plastic containers, known as the Medtainer®, that store and grind pharmaceuticals, herbs, teas and other solids or liquids.

ACTX is the leading distributor of Grow Pods. With a controlled environment, food and herbs can be grown without pesticides, harmful chemicals or risk of pathogen contamination, and with low energy consumption. Restaurants, grocery stores, non-profits, MSOs and entrepreneurs can use Grow Pods to ensure a fresh supply of ultra-clean produce year-round.

The company entered the Grow Pod business in October 2020 with its acquisition of all shares of Advanced Container Technologies Inc., a California corporation. As of February 28, 2022, ACTX is exploring the acquisition of the assets and the assumption of some or all of the liabilities of GP Solutions Inc., the developer and manufacturer of Grow Pods, for which ACTX is currently the sole U.S. distributor.

Because Grow Pods can be located almost anywhere, produce can be grown closer to the point of consumption and harvested at its peak, providing nutritious fruits and vegetables where needed. Indoor micro-farms, utilizing a practice known as vertical farming, have attracted the attention of governments and universities, which are now promoting vertical farming as a way to combat food insecurity and inequities.

The United States Department of Agriculture (USDA) has stated that vertical farming “is no longer a futuristic concept.” The department is enthusiastic about vertical farming, particularly those utilizing repurposed shipping containers, such as Grow Pods. Arizona State University reports that vertical farming reduces water use by 90 percent compared to conventional farming but produces 10 times the crop yield.


Grow Pods

One of the company’s main business units is focused on selling advanced, self-contained hydroponic containers called Grow Pods. These unique and innovative automated systems are essentially micro-farms that can be placed virtually anywhere and, with their controlled and specially filtered environment, allow cultivation of a wide variety of crops, 365 days a year. The Grow Pod controlled environment offers major advantages for the production of high-value crops. The ability to grow year-round and the ability to cultivate in a smaller footprint using less water and power are some of the primary advantages of the system. Grow Pods offer constant temperature, humidity and airflow control, as well as automated watering and lighting schedules for optimal growth and minimal labor requirements, regardless of crop.


ACTX meets the needs of the pharmaceutical and medical markets, including the cannabis and hemp industries, with patented packaging systems. The company designs, customizes, brands and sells proprietary medical grade plastic containers that can store pharmaceuticals, herbs, teas and other solids or liquids, with a special built-in feature that can grind solids and shred herbs. The company’s flagship container product is the patented Medtainer®, a child resistant, medical-grade herb container and grinder that is water-tight, air-tight and smell proof. Packaging in the cannabis industry is critical, with numerous stringent regulations about how cannabis products must be packaged and labeled. ACTX also offers custom-branded, compliant vacuum seal bags and other retail container solutions.

Equipment and Supplies

ACTX markets and sells two principal products: Grow Pods, which are specially modified insulated shipping containers manufactured by GP Solutions Inc., in which plants, herbs and spices may be grown hydroponically in a controlled environment, and Medtainers®, which may be used to store pharmaceuticals, herbs, teas and other solids or liquids and can grind solids and shred herbs. The company also markets and sells various products related to Grow Pods and the Medtainer®, as well as providing private labeling and branding services for purchasers of Medtainers® and certain related products.

GP Solutions manufactures and sells other products, such as humidity controllers and LED lighting systems for vertical farming. The company’s specially designed lighting panels are programmed to emit the exact wavelength of light that each crop requires. The system has a daybreak-to-nightfall feature that gives plants the proper chromatic signals to grow rapidly and fruitfully. High efficiency LED light strips supply the crops with a red and blue light spectrum required for photosynthesis in the spectrum that plants need most.

Market Overview

The global vertical farming market is expected to reach $33.02 billion by 2030, according to a new report by Grand View Research. The market is forecast to expand at a CAGR of 25.5 percent from 2022 to 2030, according to Grand View. Escalating production of biopharmaceutical products, including cannabis, is anticipated to drive the market. The building-based segment of the market is expected to register a significant CAGR of 27.8 percent over the projected period. In addition, the climate control segment is expected to see high growth.

The global cannabis packaging market is expected to reach $14.34 billion by 2028, according to analysis by Reports and Data. The analysis forecasts 1,700 percent growth in cannabis users by the end of 2026, with packaging likely observing a whopping 26.42 percent growth in the forecast period. There are significant barriers to entry in the cannabis packaging market, giving an advantage to companies already established in the sector. These barriers include developing a thorough knowledge of the myriad regulations that govern cannabis packaging (which differ in each state), and child-resistance requirements.

Management Team

Douglas P. Heldoorn is the Founder and Chairman of Advanced Container Technologies Inc. He also holds the positions of President, CEO and COO at the company. Mr. Heldoorn has served on the Board of Directors since its inception in 2013. He has also previously held the position of Executive General Manager at Nissan Motor Corp.

Jeffory A. Carlson is CFO and Treasurer of ACTX. Mr. Carlson has also served as the company’s Corporate Controller since 2014.

Advanced Container Technologies Inc. (OTC: ACTX), closed Friday's trading session at $0.35, off by 12.5%, on 1,851 volume. The average volume for the last 3 months is 1,851 and the stock's 52-week low/high is $0.2005/$1.4.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.